| For: | Benedict M, Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J Hepatol 2017; 9(16): 715-732 [PMID: 28652891 DOI: 10.4254/wjh.v9.i16.715] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v9/i16/715.htm |
| Number | Citing Articles |
| 1 |
Guillermo Nahúm López-Sánchez, Mayra Dóminguez-Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño-Lámbarri. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. Annals of Hepatology 2021; 21 doi: 10.1016/j.aohep.2020.04.012
|
| 2 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. La utilidad clínica de la elastografía transitoria como una herramienta de imagenología para evaluar el impacto a corto plazo de la gastrectomía laparoscópica en manga, en conjunto con parámetros clínicos y bioquímicos e índices clínico-bioquímicos en pacientes con enfermedad de hígado graso no alcohólico: un estudio piloto egipcio. Revista de Gastroenterología de México 2021; 86(2) doi: 10.1016/j.rgmx.2020.04.007
|
| 3 |
Elsayed S.I. Mohammed, Mohamed Shawky El Sayed, Tahani Ahmad Al-Matrafi, Roshmon Thomas Mathew, Mohamed Ashour, Mohammed Tariq Saud Albaloushi, Hailah M. Almohaimeed, El-Sayed Hemdan Eissa, Sameh A. Abdelnour. Sesamol-loaded PLGA nanoparticles attenuate HFD-induced MASLD by modulating Nrf2/HO-1, mitochondria cascade, and TLR4/NF-κB signaling pathways in rats. Tissue and Cell 2027; 104 doi: 10.1016/j.tice.2026.103812
|
| 4 |
I. O. Khramtsova, M. A. Derbak, T. M. Ganich, V. V. Svistak, O. T. Ganich. FREQUENCY OF THE LIVER INJURY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ACCORDING TO THE RESULTS OF NON-INVASIVE METHODS OF RESEARCH . Bulletin of Problems Biology and Medicine 2021; 3(1) doi: 10.29254/2077-4214-2021-3-161-153-157
|
| 5 |
Tielong Zhao, Yanglieguang Lou. Bidirectional Mendelian randomization analysis and systematic meta-analysis of causal relationships between hepatocellular carcinoma and non-alcoholic fatty liver disease. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03350-0
|
| 6 |
Rohit Loomba, Erin Morgan, Keyvan Yousefi, Dan Li, Richard Geary, Sanjay Bhanot, Naim Alkhouri. Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 2025; 406(10505) doi: 10.1016/S0140-6736(25)00979-1
|
| 7 |
Panyavee Pitisuttithum, Wah Kheong Chan, Panida Piyachaturawat, Kento Imajo, Atsushi Nakajima, Yosuke Seki, Kazunori Kasama, Satoru Kakizaki, Jian Gao Fan, Myeong Jun Song, Seung Kew Yoon, Yock Young Dan, Laurentius Lesmana, Khek Yu Ho, Khean Lee Goh, Vincent Wai Sun Wong, Sombat Treeprasertsuk. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01240-z
|
| 8 |
Yala K. Reddy, Hemnishil K. Marella, Yu Jiang, Surosree Ganguli, Peter Snell, Pradeep S.B. Podila, Benedict Maliakkal, Sanjaya K. Satapathy. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies. Journal of Clinical and Experimental Hepatology 2020; 10(3) doi: 10.1016/j.jceh.2019.07.002
|
| 9 |
Bokyeong Ryu, Kyung‐Yeon Eo, Ja‐Jun Jang, C‐Yoon Kim, Ji Min Lee, Hanseul Oh, Ukjin Kim, Jin Kim, Hyun‐Ho Lee, Young‐Mok Jung, Jae‐Hak Park. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata). Journal of Medical Primatology 2018; 47(4) doi: 10.1111/jmp.12347
|
| 10 |
T. Çevik Saldiran, F. Karantay Mutluay, I. Yağci, Y. Yilmaz. Comparison of aerobic and combined aerobic and whole-body vibration training effects on physical fitness in non-alcoholic fatty liver patients. Comparative Exercise Physiology 2021; 17(4) doi: 10.3920/CEP200075
|
| 11 |
Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budriesi, Saeideh Momtaz, Seyed Mohammad Nabavi, Anupam Bishayee. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders. International Journal of Molecular Sciences 2019; 20(19) doi: 10.3390/ijms20194957
|
| 12 |
Mohammed F. Abuzinadah, Aftab Ahmad. Pharmacological studies on the efficacy of a thymoquinone‐containing novel polyherbal formulation against cisplatin‐induced hepatorenal toxicity in rats. Journal of Food Biochemistry 2020; 44(2) doi: 10.1111/jfbc.13131
|
| 13 |
Joselyn N. Allen, Adwitia Dey, Jingwei Cai, Jingtao Zhang, Yuan Tian, Mary Kennett, Yanling Ma, T. Jake Liang, Andrew D. Patterson, Pamela A. Hankey-Giblin. Metabolic Profiling Reveals Aggravated Non-Alcoholic Steatohepatitis in High-Fat High-Cholesterol Diet-Fed Apolipoprotein E-Deficient Mice Lacking Ron Receptor Signaling. Metabolites 2020; 10(8) doi: 10.3390/metabo10080326
|
| 14 |
Anita Mehta, Jayesh Beladiya, Tejal Gandhi. Biochemical Mechanisms for Metabolic Syndrome. Advances in Biochemistry in Health and Disease 2024; 31 doi: 10.1007/978-3-031-75686-3_22
|
| 15 |
Manuel Suárez, Noemí Boqué, Josep Del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(10) doi: 10.3390/nu9101052
|
| 16 |
Stefan Drinda, Franziska Grundler, Thomas Neumann, Thomas Lehmann, Nico Steckhan, Andreas Michalsen, Francoise Wilhelmi de Toledo. Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational Study. Nutrients 2019; 11(11) doi: 10.3390/nu11112601
|
| 17 |
Chao-Wu Xiao, Amy Hendry. Hypolipidemic Effects of Soy Protein and Isoflavones in the Prevention of Non-Alcoholic Fatty Liver Disease- A Review. Plant Foods for Human Nutrition 2022; 77(3) doi: 10.1007/s11130-022-00984-1
|
| 18 |
Dahae Lee, Tuy An Trinh, Myoung-Sook Shin, Ki Sung Kang. Recent Advancements in Microbial Diversity. 2022; doi: 10.1016/B978-0-12-822368-0.00009-8
|
| 19 |
Stephen I. Johnson, Daniel Fort, Kenneth J. Shortt, George Therapondos, Gretchen E. Galliano, Theresa Nguyen, Edward I. Bluth. Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index. Diagnostics 2021; 11(8) doi: 10.3390/diagnostics11081443
|
| 20 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271 doi: 10.1016/j.lfs.2021.119220
|
| 21 |
Bhagyalakshmi Nair, Adithya Jayaprakash Kamath, Vinay Tergaonkar, Gautam Sethi, Lekshmi R. Nath. Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy. Life Sciences 2024; 351 doi: 10.1016/j.lfs.2024.122818
|
| 22 |
Christian S. Alvarez, Andrea A. Florio, Julia Butt, Alvaro Rivera‐Andrade, María F. Kroker‐Lobos, Tim Waterboer, Maria Constanza Camargo, Neal D. Freedman, Barry I. Graubard, Mariana Lazo, Eliseo Guallar, John D. Groopman, Manuel Ramírez‐Zea, Katherine A. McGlynn. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. Helicobacter 2020; 25(6) doi: 10.1111/hel.12756
|
| 23 |
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(8) doi: 10.1080/17425255.2018.1492552
|
| 24 |
Martin Burian, Milan Hajek, Petr Sedivy, Irena Mikova, Pavel Trunecka, Monika Dezortova. Lipid Profile and Hepatic Fat Content Measured by 1H MR Spectroscopy in Patients before and after Liver Transplantation. Metabolites 2021; 11(9) doi: 10.3390/metabo11090625
|
| 25 |
Silvia Gancheva, Irina Ivanova, Antonia Atanassova, Diana Gancheva-Tomova, Miroslav Eftimov, Klementina Moneva, Maria Zhelyazkova-Savova, Stefka Valcheva-Kuzmanova. Effects of Aronia melanocarpa fruit juice on oxidative stress, energy homeostasis, and liver function in overweight and healthy-weight individuals. Scripta Scientifica Medica 2021; 53(4) doi: 10.14748/ssm.v0i0.7833
|
| 26 |
Milena Vesković, Milica Labudović-Borović, Dušan Mladenović, Jelena Jadžić, Bojan Jorgačević, Dušan Vukićević, Danijela Vučević, Tatjana Radosavljević. Effect of Betaine Supplementation on Liver Tissue and Ultrastructural Changes in Methionine–Choline-Deficient Diet-Induced NAFLD. Microscopy and Microanalysis 2020; 26(5) doi: 10.1017/S1431927620024265
|
| 27 |
Mingwei Tong, Xiaodan Yang, Yuyu Qiao, Ge Liu, Huihui Ge, Guangrong Huang, Yanhong Wang, Yong Yang, Weiping Fan. Serine protease inhibitor from the muscle larval Trichinella spiralis ameliorates non-alcoholic fatty liver disease in mice via anti-inflammatory properties and gut-liver crosstalk. Biomedicine & Pharmacotherapy 2024; 172 doi: 10.1016/j.biopha.2024.116223
|
| 28 |
Moein Askarpour, Kurosh Djafarian, Ehsan Ghaedi, Omid Sadeghi, Ali Sheikhi, Sakineh Shab-Bidar. Effect of L-Carnitine Supplementation on Liver Enzymes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Archives of Medical Research 2020; 51(1) doi: 10.1016/j.arcmed.2019.12.005
|
| 29 |
Cheng‐Cheng Zhao, Xin‐Yue Wu, Huan Yi, Rong Chen, Gang Fan. The Therapeutic Effects and Mechanisms of Salidroside on Cardiovascular and Metabolic Diseases: An Updated Review. Chemistry & Biodiversity 2021; 18(7) doi: 10.1002/cbdv.202100033
|
| 30 |
Shuxuan Li, Yao Zhi, Wentao Mu, Mingqian Li, Guoyue Lv. Exploring the effects of epigallocatechin gallate on lipid metabolism in the rat steatotic liver during normothermic machine perfusion: Insights from lipidomics and RNA sequencing. European Journal of Pharmacology 2024; 964 doi: 10.1016/j.ejphar.2023.176300
|
| 31 |
Aishwarya Venkatasubramanian, Anand Thiyagaraj, Vairamuthu Subbiah, Solaipriya Solairaja, Sangaran Arumugam, Satish Ramalingam, Sivaramakrishnan Venkatabalasubramanian. Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental model. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 2021; 247 doi: 10.1016/j.cbpc.2021.109061
|
| 32 |
Xihui Xu, Rozhin Penjweini, Lóránt Székvölgyi, Zsolt Karányi, Anne-Marie Heckel, Devikala Gurusamy, Dóra Varga, Shutong Yang, Alexandra L. Brown, Wenqi Cui, Jinsung Park, Dénes Nagy, Maren C. Podszun, Sarah Yang, Komudi Singh, Stephen P. Ashcroft, Jeonghan Kim, Myung K. Kim, Ivan Tarassov, Jun Zhu, Andrew Philp, Yaron Rotman, Jay R. Knutson, Nina Entelis, Jay H. Chung.
Endonuclease G promotes hepatic mitochondrial respiration by selectively increasing mitochondrial tRNA
Thr
production
. Proceedings of the National Academy of Sciences 2025; 122(1) doi: 10.1073/pnas.2411298122
|
| 33 |
Chieh-Yu Liao, Fanta Barrow, Nanditha Venkatesan, Yasuhiko Nakao, Amy S. Mauer, Gavin Fredrickson, Myeong Jun Song, Tejasav S. Sehrawat, Debanjali Dasgupta, Rondell P. Graham, Xavier S. Revelo, Harmeet Malhi. Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1130184
|
| 34 |
Anca Bălănescu, Iustina Stan, Ioana Codreanu, Valentina Comănici, Eugenia Bălănescu, Paul Bălănescu. Circulating Hsp90 Isoform Levels in Overweight and Obese Children and the Relation to Nonalcoholic Fatty Liver Disease: Results from a Cross-Sectional Study. Disease Markers 2019; 2019 doi: 10.1155/2019/9560247
|
| 35 |
Yang Liu, Kevin D. Croft, Jose Caparros-Martin, Fergal O'Gara, Trevor A. Mori, Natalie C. Ward. Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease. Archives of Biochemistry and Biophysics 2021; 711 doi: 10.1016/j.abb.2021.109032
|
| 36 |
Justin D. Schumacher, Grace L. Guo. Bile Acids and Their Receptors. Handbook of Experimental Pharmacology 2019; 256 doi: 10.1007/164_2019_228
|
| 37 |
Salwa Seddik Hosny, Hanan Mahmoud Ali, Wesam Ahmed Mohammed, Mohamed Hesham El Ghannam. Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3) doi: 10.1016/j.dsx.2019.04.002
|
| 38 |
Weiping Wei, Yunqian Li, Yongyong Li, Daoyuan Li. Adipose-specific knockout of ubiquitin-conjugating enzyme E2L6 (Ube2l6) reduces diet-induced obesity, insulin resistance, and hepatic steatosis. Journal of Pharmacological Sciences 2021; 145(4) doi: 10.1016/j.jphs.2020.12.008
|
| 39 |
Mohamed Sayed, Ebthal Mahmoud Abozeid, Hoda M. Amin, Naglaa M. Elsayed, Yasser H. Nassar, Hend A. Elsheimy. Non-alcoholic Fatty Liver and Vitamin D Levels in Extremely Obese Individuals: A Case–Control Study. Open Access Macedonian Journal of Medical Sciences 2021; 9(B) doi: 10.3889/oamjms.2021.5976
|
| 40 |
Roberta Catania, Leo Jia, Maryam Haghshomar, Frank H. Miller, Amir A. Borhani. Detection of moderate hepatic steatosis on contrast-enhanced dual-source dual-energy CT: Role and accuracy of virtual non-contrast CT. European Journal of Radiology 2024; 172 doi: 10.1016/j.ejrad.2024.111328
|
| 41 |
Sarina Kajani, Rhianna C. Laker, Ekaterina Ratkova, Sarah Will, Christopher J. Rhodes. Hepatic glucagon action: beyond glucose mobilization. Physiological Reviews 2024; 104(3) doi: 10.1152/physrev.00028.2023
|
| 42 |
O.Ya. Babak, N.M. Zhelezniakova, A.O. Rozhdestvenska . The potential role of kallistatin as a new biomarker in non-invasive diagnostics of non-alcoholic fatty liver disease with hypertension. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2019; 2019(2) doi: 10.15407/internalmed2019.02.018
|
| 43 |
Aynur Arslan, Özgür Şimşek, Aykut Turhan, Ayşe Çarlıoğlu, Şenay Arıkan, Mustafa Utlu, Emine Kartal Baykan. Non-alcoholic fatty liver disease in patients with familial hypercholesterolemia. Ortadoğu Tıp Dergisi 2020; 12(2) doi: 10.21601/ortadogutipdergisi.722778
|
| 44 |
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overview. Journal of Prescribing Practice 2020; 2(4) doi: 10.12968/jprp.2020.2.4.200
|
| 45 |
Katharina L. Hupa, Elmar Jaeckel, Michael P. Manns. Silymarin for Treatment of Nonalcoholic Steatohepatitis–A New Kid on the Block?. Clinical Gastroenterology and Hepatology 2017; 15(12) doi: 10.1016/j.cgh.2017.08.005
|
| 46 |
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle, Yuriy K. Bashmakov. Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report. International Journal of Chronic Diseases 2018; 2018 doi: 10.1155/2018/4549614
|
| 47 |
Eunha Chang, Jae Seung Chang, In Deok Kong, Soon Koo Baik, Moon Young Kim, Kyu-Sang Park. Multidimensional Biomarker Analysis Including Mitochondrial Stress Indicators for Nonalcoholic Fatty Liver Disease. Gut and Liver 2022; 16(2) doi: 10.5009/gnl210106
|
| 48 |
Kai-Ting Chuang, Li-Ting Wang, Shih-Hsien Hsu. Role of Wnt Ligand Secretion Mediator Signaling in Cancer Development. Journal of Cancer Research and Practice 2023; 10(1) doi: 10.4103/ejcrp.eJCRP-D-22-00029
|
| 49 |
Xin Jiang, Fan Zhang, Xueying Ji, Fangyuan Dong, Huiyuan Yu, Mengjuan Xue, Yixuan Qiu, Fan Yang, Xiaona Hu, Zhijun Bao. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling. Cytokine 2021; 142 doi: 10.1016/j.cyto.2021.155474
|
| 50 |
Hui ZHOU, YiWen HE, YuLong YIN, TieJun LI, LiuQin HE. Role of selenium and selenoprotein in animal liver health. SCIENTIA SINICA Vitae 2024; doi: 10.1360/SSV-2024-0107
|
| 51 |
Arslan Ahmad, Shazia Siddique, Amanullah Bhalli, Amina Umer, Umayma Asad, Muhammad Irfan Jamil. Frequency and Association of Dyslipidemia with Clinical and Biochemical Parameters among Patients with Non-alcoholic Fatty Liver Disease. Pakistan Journal of Health Sciences 2025; doi: 10.54393/pjhs.v6i12.3349
|
| 52 |
M. V. Pecherskikh, L. I. Efremova. Intrahepatic cholestasis and its correction in patients with chronic acalculous cholecystitis. Experimental and Clinical Gastroenterology 2023; (10) doi: 10.31146/1682-8658-ecg-206-10-32-38
|
| 53 |
Yu-Ping Lin, Qiong-Lian Fang, Sheng-Nan Fu, Xin-Ping Li, Rui Shi, Cheng-Hong Du, Xue Qiao, Xun-Qing Yin, Yong-Cheng Zeng, Xiu-Juan Zhao, Yan Hua. The alleviating effect of Scutellaria amoena extract on the regulation of gut microbiota and its metabolites in NASH rats by inhibiting the NLRP3/ASC/caspase-1 axis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1143785
|
| 54 |
Fabiana Kurokawa Hasimoto, Fabiane Valentini Francisqueti-Ferron, Mariane Róvero Costa, Marajane Bruno de Souza, Aline Garcia Aun, Flávia Ribeiro Nogueira, Pedro Henrique Rizzi Alves, Giuseppina Pace Pereira Lima, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Igor Otávio Minatel, Fernando Moreto, Mariana Gobbo Braz, Camila Renata Corrêa. Therapeutic effect of Curcuma longa L. on the nonalcoholic fatty liver disease (NAFLD) physiopathology due fructose consumption. Nutrire 2020; 45(2) doi: 10.1186/s41110-020-00127-z
|
| 55 |
Saurabh Chatterjee, Madhura More. Cyanobacterial Harmful Algal Bloom Toxin Microcystin and Increased Vibrio Occurrence as Climate-Change-Induced Biological Co-Stressors: Exposure and Disease Outcomes via Their Interaction with Gut–Liver–Brain Axis. Toxins 2023; 15(4) doi: 10.3390/toxins15040289
|
| 56 |
Vik Meadows, Lindsey Kennedy, Debjyoti Kundu, Gianfranco Alpini, Heather Francis. Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00015
|
| 57 |
Meltem Yalçın, Mehtap Kaçar. Investigation of the hepatic mTOR/S6K1/SREBP1 signalling pathway in rats at different ages: from neonates to adults. Molecular Biology Reports 2021; 48(11) doi: 10.1007/s11033-021-06757-4
|
| 58 |
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. American Society of Clinical Oncology Educational Book 2018; (38) doi: 10.1200/EDBK_200939
|
| 59 |
Md. Abdul Hannan, Md. Ataur Rahman, Abdullah Al Mamun Sohag, Md. Jamal Uddin, Raju Dash, Mahmudul Hasan Sikder, Md. Saidur Rahman, Binod Timalsina, Yeasmin Akter Munni, Partha Protim Sarker, Mahboob Alam, Md. Mohibbullah, Md. Nazmul Haque, Israt Jahan, Md. Tahmeed Hossain, Tania Afrin, Md. Mahbubur Rahman, Md. Tahjib-Ul-Arif, Sarmistha Mitra, Diyah Fatimah Oktaviani, Md Kawsar Khan, Ho Jin Choi, Il Soo Moon, Bonglee Kim. Black Cumin (Nigella sativa L.): A Comprehensive Review on Phytochemistry, Health Benefits, Molecular Pharmacology, and Safety. Nutrients 2021; 13(6) doi: 10.3390/nu13061784
|
| 60 |
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan. Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases. Comprehensive Physiology 2022; 12(2) doi: 10.1002/j.2040-4603.2022.tb00210.x
|
| 61 |
Narsimha Keetha Rao, Shahriar Ghodous, Anoop Gurram, Mehrdad Khorasani, Madhusudhan Ponnala, Arman Habibi, Kwame Agyeman, Parsa Saberian, Pubali Biswas, Negin Letafatkar, Simran Joshi, Yasmin Sahli, Reza Amani-Beni, Bahar Darouei, Yussif Issaka, Kiran Sandilya Balivada, Farahnaz Joukar, Amir Nasrollahizadeh, Anderson Ogazi, Mohammad Amin Karimi, Michael T Ulrich, Mohammad-Hossein Keivanlou, Mohammad-Javad Khosousi, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi, Sandeep S Nayak. Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease: An Updated Global Systematic Review and Meta-Analysis of over 1.5 Million Individuals. Inflammatory Bowel Diseases 2026; 32(2) doi: 10.1093/ibd/izaf226
|
| 62 |
Yu-Chen Liu, Gang Wei, Zhi-Qiang Liao, Fang-Xin Wang, Chunxiao Zong, Jiannan Qiu, Yifei Le, Zhi-Ling Yu, Seo Young Yang, Heng-Shan Wang, Xiao-Bing Dou, Cai-Yi Wang. Design and Synthesis of Novel Indole Ethylamine Derivatives as a Lipid Metabolism Regulator Targeting PPARα/CPT1 in AML12 Cells. Molecules 2023; 29(1) doi: 10.3390/molecules29010012
|
| 63 |
Kush Kumar Pandey, Deeksha Madhry, Y.S. Ravi Kumar, Shivani Malvankar, Leena Sapra, Rupesh K. Srivastava, Sankar Bhattacharyya, Bhupendra Verma. Regulatory roles of tRNA-derived RNA fragments in human pathophysiology. Molecular Therapy - Nucleic Acids 2021; 26 doi: 10.1016/j.omtn.2021.06.023
|
| 64 |
Shuai Chen, Yicheng Jiang, Xiaoyang Qi, Peng Song, Liming Tang, Hanyang Liu. Bioinformatics analysis to obtain critical genes regulated in subcutaneous adipose tissue after bariatric surgery. Adipocyte 2022; 11(1) doi: 10.1080/21623945.2022.2115212
|
| 65 |
Sylwia Szeląg-Pieniek, Stefan Oswald, Mariola Post, Joanna Łapczuk-Romańska, Marek Droździk, Mateusz Kurzawski. Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure. Pharmacological Reports 2021; 73(5) doi: 10.1007/s43440-021-00290-8
|
| 66 |
Daiane T. Oliveira, Adriano B. Chaves-Filho, Marcos Y. Yoshinaga, Nívia Carolina N. Paiva, Cláudia M. Carneiro, Sayuri Miyamoto, William T. Festuccia, Renata Guerra-Sá. Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar diet. The Journal of Nutritional Biochemistry 2021; 87 doi: 10.1016/j.jnutbio.2020.108519
|
| 67 |
Xiaoqin Zhu, Chuanfei Zeng, Baoping Yu. White adipose tissue in metabolic associated fatty liver disease. Clinics and Research in Hepatology and Gastroenterology 2024; 48(5) doi: 10.1016/j.clinre.2024.102336
|
| 68 |
Ashley Cast, Meenasri Kumbaji, Amber D'Souza, Katherine Rodriguez, Anita Gupta, Rebekah Karns, Lubov Timchenko, Nikolai Timchenko. Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease. Hepatology Communications 2019; 3(8) doi: 10.1002/hep4.1381
|
| 69 |
Edomias Adyamseged Berhe, Rediet Ambachew Sema, Yididya Mehari Tesfaye, Abel Andargie Berhane, Mikale Dawit, Ephrem Mamo Gebrehiwot, Subah Abderehim Yesuf, Balamurugan Ramatchandirin. Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia. Journal of Diabetes Research 2025; 2025(1) doi: 10.1155/jdr/5555842
|
| 70 |
Ke Li, Wen-hong Wang, Jia-bin Wu, Wei-hua Xiao. β-hydroxybutyrate: A crucial therapeutic target for diverse liver diseases. Biomedicine & Pharmacotherapy 2023; 165 doi: 10.1016/j.biopha.2023.115191
|
| 71 |
Feng-Juan Yan, Yong-Jian Wang, Shi-Ran Yan, Jun Lu, Yuan-Lin Zheng. ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARα. Biochemical Journal 2019; 476(2) doi: 10.1042/BCJ20180517
|
| 72 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169 doi: 10.1016/j.prostaglandins.2023.106766
|
| 73 |
Evaluation of hepcidin and its relationship with iron in non-alcoholic fatty liver disease. Biomedicine 2022; 42(1) doi: 10.51248/.v42i1.680
|
| 74 |
Naveen Kaushal, Megha Gupta, Era Kulshreshtha. Hempseed (Cannabis sativa) lipid fractions alleviate high-fat diet-induced fatty liver disease through regulation of inflammation and oxidative stress. Heliyon 2020; 6(7) doi: 10.1016/j.heliyon.2020.e04422
|
| 75 |
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. F1000Research 2020; 9 doi: 10.12688/f1000research.21918.1
|
| 76 |
Zahra Maleki, Shima Jazayeri, Omid Eslami, Farzad Shidfar, Agha Fatemeh Hosseini, Shahram Agah, Hamed Norouzi. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Complementary Therapies in Medicine 2019; 44 doi: 10.1016/j.ctim.2019.02.020
|
| 77 |
Musaab Ahmed, Mohamed H Ahmed. Nonalcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic. World Journal of Clinical Cases 2021; 9(17): 4133-4142 doi: 10.12998/wjcc.v9.i17.4133
|
| 78 |
Danijela Ristic-Medic, Joanna Bajerska, Vesna Vucic. Crosstalk between dietary patterns, obesity and nonalcoholic fatty liver disease. World Journal of Gastroenterology 2022; 28(27): 3314-3333 doi: 10.3748/wjg.v28.i27.3314
|
| 79 |
M S Deepa, V C Indulekha, Indu M Menon. Therapeutic potential of Triphala and Gomutra in the management of non-alcoholic fatty liver disease: A review. Journal of Drug Research in Ayurvedic Sciences 2024; 9(1) doi: 10.4103/jdras.jdras_43_23
|
| 80 |
Célio Junior da Costa Fernandes, Vivian Cristina da Cruz Rodrigues, Gustavo José de Sá Pereira, Diego Gomes de Melo, Thaís Dantis Pereira de Campos, Raphael dos Santos Canciglieri, Rodrigo Augusto Foganholi da Silva, Adelino Sanchez Ramos da Silva, José Rodrigo Pauli, Atan Gross, Leandro Pereira de Moura. Epigenetically modulated MTCH2 and regulated ATP5 in the liver of obese mice subjected to strength training. Life Sciences 2026; 384 doi: 10.1016/j.lfs.2025.124105
|
| 81 |
Jie Xing, Xue Guan, Qian Zhang, Shuohua Chen, Shouling Wu, Xiujing Sun. Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study. Obesity Facts 2021; 14(2) doi: 10.1159/000514848
|
| 82 |
Juan-Fen Mo, Jia-Yuan Wu, Li Zheng, Ya-Wei Yu, Tian-Xin Zhang, Li Guo, Yi Bao. Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice. RSC Advances 2018; 8(54) doi: 10.1039/C8RA05915B
|
| 83 |
Iris Pinheiro. A Comprehensive Guide to Non-alcoholic Fatty Liver Disease. 2024; doi: 10.5772/intechopen.1007741
|
| 84 |
Amal Ahmed Mohamed, Ahmed Abdel Halim, Sahar Mohamed, Seham Mohamed Mahmoud, Eman Mohamed Bahgat Eldemiry, Rasha Sobh Mohamed, Mahmoud Maamoun Shaheen, Gina G. Naguib, Nashwa M. Muharram, Mona G. Khalil, Salma Saed, Randa Ibrahim, Ahmed Salah Seif, Noha Kamal, Karima Nasraldin, Ali Elsaid Abdelrahman, Radwa El Borolossy. The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1149967
|
| 85 |
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?. Experimental Neurology 2020; 325 doi: 10.1016/j.expneurol.2019.113160
|
| 86 |
Ioannis Akoumianakis, Anastasios Zagaliotis, Maria Konstantaraki, Theodosios D. Filippatos. GLP‐1 analogs and regional adiposity: A systematic review and meta‐analysis. Obesity Reviews 2023; 24(8) doi: 10.1111/obr.13574
|
| 87 |
Shehwaz Anwar, Hajed Obaid A. Alharbi, Ali Yousif Babiker, Arshad Husain Rahmani. Oxidative Stress in Health and Disease: Mechanisms and Therapeutic Perspectives. International Journal of Molecular Sciences 2026; 27(6) doi: 10.3390/ijms27062681
|
| 88 |
Xiao Li, Virgia Wang. Genetic evidence for the causal relationship between NAFLD and brain functional connectivity. 2022 6th International Conference on Biomedical Engineering and Applications (ICBEA) 2022; doi: 10.1145/3543081.3543093
|
| 89 |
Hye-Rin Ahn, Seung-Won Lee, Da-Young Lee, Moon-Young Song, Young-Min Han, Byeong Yeob Jeon, You-Kyung Jang, Eun-Hee Kim. Hongjam, an edible silkworm-derived food, attenuates steatohepatitis and fibrosis via multi-axis modulation of metabolic stress, inflammation, and fibrogenic signaling. Frontiers in Nutrition 2026; 13 doi: 10.3389/fnut.2026.1839551
|
| 90 |
Yuchang Li, Liting Chen, Vassilios Papadopoulos. The mitochondrial translocator protein (TSPO, 18 kDa): A key multifunctional molecule in liver diseases. Biochimie 2024; 224 doi: 10.1016/j.biochi.2023.11.013
|
| 91 |
Chris Boesch. Quantitative MR Imaging Is Increasingly Important in Liver Disease. Radiology 2018; 286(2) doi: 10.1148/radiol.2017172312
|
| 92 |
Pierangelo Torquato, Desirée Bartolini, Danilo Giusepponi, Marta Piroddi, Bartolomeo Sebastiani, Giorgio Saluti, Roberta Galarini, Francesco Galli. Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects. Free Radical Biology and Medicine 2019; 131 doi: 10.1016/j.freeradbiomed.2018.11.036
|
| 93 |
Hany A. Abdel Samie, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar, Mohammad A. Kamal. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular Carcinoma. Current Drug Metabolism 2019; 20(4) doi: 10.2174/1389200220666190308134351
|
| 94 |
Robin H. Isaacson, Juliane I. Beier, Nicholas KH Khoo, Bruce A. Freeman, Zachary Freyberg, Gavin E. Arteel. Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane. The Journal of Nutritional Biochemistry 2020; 81 doi: 10.1016/j.jnutbio.2020.108399
|
| 95 |
Xiaofang Zhang, Caoxin Huang, Xuejun Li, Zhaoshui Shangguan, Wenjing Wei, Suhuan Liu, Shuyu Yang, Yijie Liu. HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01515-5
|
| 96 |
Fatemeh Naeini, Zahra Namkhah, Helda Tutunchi, Seyed Mahdi Rezayat, Siavash Mansouri, Seyed Ali Jazayeri-Tehrani, Mehdi Yaseri, Mohammad Javad Hosseinzadeh-Attar. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial. Trials 2021; 22(1) doi: 10.1186/s13063-021-05784-7
|
| 97 |
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J. Lamb, Albert de Roos, Frits R. Rosendaal, Renée de Mutsert. Adherence to dietary guidelines in relation to visceral fat and liver fat in middle-aged men and women: the NEO study. International Journal of Obesity 2020; 44(2) doi: 10.1038/s41366-019-0441-x
|
| 98 |
Moumita Saha, Sanjib Das, Krishnendu Manna, Krishna Das Saha. Melatonin targets ferroptosis through bimodal alteration of redox environment and cellular pathways in NAFLD model. Bioscience Reports 2023; 43(10) doi: 10.1042/BSR20230128
|
| 99 |
Yuhei Mizunoe, Masaki Kobayashi, Ryoma Tagawa, Yoshimi Nakagawa, Hitoshi Shimano, Yoshikazu Higami. Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic Syndrome. International Journal of Molecular Sciences 2019; 20(15) doi: 10.3390/ijms20153688
|
| 100 |
Michael J. Nash, Evgenia Dobrinskikh, Sean A. Newsom, Ilhem Messaoudi, Rachel C. Janssen, Kjersti M. Aagaard, Carrie E. McCurdy, Maureen Gannon, Paul Kievit, Jacob E. Friedman, Stephanie R. Wesolowski. Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring. JCI Insight 2021; 6(24) doi: 10.1172/jci.insight.154093
|
| 101 |
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular Disease. Contemporary Cardiology 2021; doi: 10.1007/978-3-030-62632-7_9
|
| 102 |
Qian Chen, Mengyang Liu, Haiyang Yu, Jian Li, Sijian Wang, Yi Zhang, Feng Qiu, Tao Wang. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway. Journal of Natural Medicines 2018; 72(3) doi: 10.1007/s11418-018-1199-5
|
| 103 |
Meghan May, Deborah Barlow, Radwa Ibrahim, Karen L. Houseknecht. Mechanisms Underlying Antipsychotic-Induced NAFLD and Iron Dysregulation: A Multi-Omic Approach. Biomedicines 2022; 10(6) doi: 10.3390/biomedicines10061225
|
| 104 |
Geng-Ruei Chang, Hsien-Yueh Liu, Wei-Cheng Yang, Chao-Min Wang, Ching-Fen Wu, Jen-Wei Lin, Wei-Li Lin, Yu-Chen Wang, Tzu-Chun Lin, Huei-Jyuan Liao, Po-Hsun Hou, Chee-Hong Chan, Chuen-Fu Lin. Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice. International Journal of Molecular Sciences 2021; 22(13) doi: 10.3390/ijms22136680
|
| 105 |
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel disease: when transient elastography makes the difference. European Journal of Gastroenterology & Hepatology 2019; 31(8) doi: 10.1097/MEG.0000000000001319
|
| 106 |
Yuchang Li, Liting Chen, Lu Li, Chantal Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito, Lucy Golden-Mason, Hugo R. Rosen, Jeremy J. Wolff, Cristina I. Silvescu, Samuel Garza, Garett Cheung, Tiffany Huang, Jinjiang Fan, Martine Culty, Bangyan Stiles, Kinji Asahina, Vassilios Papadopoulos. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. iScience 2021; 24(5) doi: 10.1016/j.isci.2021.102457
|
| 107 |
Joseph Carpenter, Gang Wu, Ying Wang, Erica M. Cook, Tao Wang, Doree Sitkoff, Karen A. Rossi, Kathy Mosure, Xiaoliang Zhuo, Gary G. Cao, Milinda Ziegler, Anthony V. Azzara, Jack Krupinski, Matthew G. Soars, Bruce Alan Ellsworth, Dean A. Wacker. Discovery of BMS-986318, a Potent Nonbile Acid FXR Agonist for the Treatment of Nonalcoholic Steatohepatitis. ACS Medicinal Chemistry Letters 2021; 12(9) doi: 10.1021/acsmedchemlett.1c00198
|
| 108 |
Michalina Banaszak, Małgorzata Dobrzyńska, Anna Kawka, Ilona Górna, Dagmara Woźniak, Juliusz Przysławski, Sławomira Drzymała-Czyż. Role of Omega-3 fatty acids eicosapentaenoic (EPA) and docosahexaenoic (DHA) as modulatory and anti-inflammatory agents in noncommunicable diet-related diseases – Reports from the last 10 years. Clinical Nutrition ESPEN 2024; 63 doi: 10.1016/j.clnesp.2024.06.053
|
| 109 |
Getnet Teshome, Sintayehu Ambachew, Alebachew Fasil, Molla Abebe. <p>Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review</p>. Hepatic Medicine: Evidence and Research 2020; doi: 10.2147/HMER.S265631
|
| 110 |
Chang Li, Jing Ye, Yun Peng, Weiqiang Dou, Songan Shang, Jingtao Wu, Ramin Jafari, Kelly McCabe Gillen, Yi Wang, Martin Prince, Xianfu Luo. Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit model. Magnetic Resonance Imaging 2019; 63 doi: 10.1016/j.mri.2019.08.032
|
| 111 |
Bingwei Ma, Hang Sun, Bing Zhu, Shilin Wang, Lei Du, Xingchun Wang, Shen Qu. Hepatic Steatosis Is Associated with Elevated Serum Iron in Patients with Obesity and Improves after Laparoscopic Sleeve Gastrectomy. Obesity Facts 2021; 14(1) doi: 10.1159/000511736
|
| 112 |
Esther Rey, Elvira del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García-García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García-Monzón, Isaac Almendros, Águeda González-Rodríguez. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00450
|
| 113 |
Di-Shuang Hu, Sheng-Hao Zhu, Xu Li, Qin-Fen Chen, Chun-Jing Lin, Dan-Hong Fang, Jian-Sheng Wu. Association between Hemoglobin Glycation Index and NAFLD in Chinese Nondiabetic Individuals. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/8748459
|
| 114 |
Rosanna Villani, Pierluigi Lupo, Moris Sangineto, Antonino Davide Romano, Gaetano Serviddio. Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary. Diagnostics 2023; 13(7) doi: 10.3390/diagnostics13071236
|
| 115 |
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
|
| 116 |
Marco Raffaele, Lars Bellner, Shailendra P. Singh, Gaia Favero, Rita Rezzani, Luigi Fabrizio Rodella, John R. Falck, Nader G. Abraham, Luca Vanella. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1α mitochondrial signaling. Experimental Cell Research 2019; 380(2) doi: 10.1016/j.yexcr.2019.04.029
|
| 117 |
Doaa El Amrousy, Dina Abdelhai, Dina Shawky. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial. European Journal of Pediatrics 2022; 181(2) doi: 10.1007/s00431-021-04243-4
|
| 118 |
Arne Janssen, Diederick E Grobbee, Paul Dendale. Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease. European Journal of Preventive Cardiology 2020; 27(10) doi: 10.1177/2047487319891783
|
| 119 |
Lin Xu, Yuanjun Lu, Ning Wang, Yibin Feng. The Role and Mechanisms of Selenium Supplementation on Fatty Liver-Associated Disorder. Antioxidants 2022; 11(5) doi: 10.3390/antiox11050922
|
| 120 |
Tristan Joseph C. Limchesing, Nilo T. Bugtai, Renann G. Baldovino. Implementation of Neural Network for the Liver Disease Classification. 2020 International Conference on Applied Science and Technology (iCAST) 2020; doi: 10.1109/iCAST51016.2020.9557639
|
| 121 |
Isabel Hidalgo, Miguel Ortiz-Flores, Francisco Villarreal, Salvador Fonseca-Coronado, Guillermo Ceballos, Eduardo Meaney, Nayelli Nájera. Is it possible to treat nonalcoholic liver disease using a flavanol-based nutraceutical approach? Basic and clinical data. Journal of Basic and Clinical Physiology and Pharmacology 2022; 33(6) doi: 10.1515/jbcpp-2021-0285
|
| 122 |
Sowmya Mekala, Prachi Dugam, Amitava Das. Ephrin–Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies. Journal of Cell Communication and Signaling 2023; 17(3) doi: 10.1007/s12079-023-00750-1
|
| 123 |
Eréndira Villanueva-Ortega, María José Garcés-Hernández, Arturo Herrera-Rosas, Juan Carlos López-Alvarenga, Estibalitz Laresgoiti-Servitje, Galileo Escobedo, Gloria Queipo, Sergio Cuevas-Covarrubias, Guadalupe Nayely Garibay-Nieto. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric population. Annals of Hepatology 2019; 18(5) doi: 10.1016/j.aohep.2019.04.012
|
| 124 |
Zuo-Di Fu, Xiao-Ling Cai, Wen-Jia Yang, Ming-Ming Zhao, Ran Li, Yu-Feng Li. Novel glucose-lowering drugs for non-alcoholic fatty liver disease. World Journal of Diabetes 2021; 12(1): 84-97 doi: 10.4239/wjd.v12.i1.84
|
| 125 |
Selin Gencer, Yvonne Döring, Yvonne Jansen, Soyolmaa Bayasgalan, Olga Schengel, Madeleine Müller, Linsey J. F. Peters, Christian Weber, Emiel P. C. van der Vorst. Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose Tissue. Biomedicines 2021; 9(4) doi: 10.3390/biomedicines9040394
|
| 126 |
Carolyne Pimentel Rosado, Victor Hugo Cordeiro Rosa, Bruna Cadete Martins, Aruanna Cajaty Soares, Izabelle Barcellos Santos, Elisa Bernardes Monteiro, Nathália Moura-Nunes, Cristiane Aguiar da Costa, Alessandra da Rocha Pinheiro Mulder, Julio Beltrame Daleprane. Resistant starch from green banana (Musa sp.) attenuates non-alcoholic fat liver accumulation and increases short-chain fatty acids production in high-fat diet-induced obesity in mice. International Journal of Biological Macromolecules 2020; 145 doi: 10.1016/j.ijbiomac.2019.09.199
|
| 127 |
Katherine Stern, H. Laura Aaltonen, Mike Weykamp, Devin Gaskins, Qian Qui, Grant O'Keefe, Alyson Littman, Ken Linnau, Ali Rowhani-Rahbar. Associations of Fatty Liver Disease With Recovery After Traumatic Injury. Journal of Surgical Research 2023; 291 doi: 10.1016/j.jss.2023.06.014
|
| 128 |
Anandarupa Neogi, Anubhav Jaiswal, Ankush Kumar, Jyoti Anand, Bikash Sadhukhan. Predictive Modeling for Mortality Risk in Nonalcoholic Fatty Liver Disease Patients: A Machine Learning Approach. 2024 Second International Conference on Data Science and Information System (ICDSIS) 2024; doi: 10.1109/ICDSIS61070.2024.10594545
|
| 129 |
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya. Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review. Preventive Medicine: Research & Reviews 2025; 2(4) doi: 10.4103/PMRR.PMRR_159_24
|
| 130 |
Emir Tas, Shasha Bai, Xiawei Ou, Kelly Mercer, Haixia Lin, Kori Mansfield, Robert Buchmann, Eva C. Diaz, Jon Oden, Elisabet Børsheim, Sean H. Adams, Jonathan Dranoff. Fibroblast Growth Factor-21 to Adiponectin Ratio: A Potential Biomarker to Monitor Liver Fat in Children With Obesity. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00654
|
| 131 |
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double‐blind, placebo‐controlled, clinical trial. International Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14852
|
| 132 |
Vishal Kothari, Christopher Savard, Jingjing Tang, Sum P. Lee, Savitha Subramanian, Shari Wang, Laura J. den Hartigh, Karin E. Bornfeldt, George N. Ioannou. sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation. Hepatology Communications 2023; 7(11) doi: 10.1097/HC9.0000000000000265
|
| 133 |
Rasoul Shafiezadeh, Seyed Moayed Alavian, Hasan Namdar, Mohammad Gholami-Fesharaki, Seyed Saeid Esmaeili. Evaluating the Efficacy of Carum Copticum Seeds on the Treatment of Patients with Nonalcoholic Fatty Liver Disease: A Multi-Center, Randomized, Triple–Blind, Placebo-Controlled Clinical Trial Study. Hepatitis Monthly 2021; 20(12) doi: 10.5812/hepatmon.110488
|
| 134 |
Sophie E. Kastberg, Helene S. Lund, Emanuella De Lucia‐Rolfe, Lydia U. Kaduka, Michael K. Boit, Eva Corpeleijn, Henrik Friis, Sophie Bernard, Martine Paquette, Alexis Baass, Jon J. Rasmussen, Dirk L. Christensen. Hepatic steatosis is associated with anthropometry, cardio‐metabolic disease risk, sex, age and urbanisation, but not with ethnicity in adult Kenyans. Tropical Medicine & International Health 2022; 27(1) doi: 10.1111/tmi.13696
|
| 135 |
P. F. Peppi, G. A. Lira, L. R. S. Campos, C. R. Santos, E. M. M. Lima, A. R. C. Barreto-Vianna. Liver under attack: impacts of high-fat diet on murine model. Brazilian Journal of Biology 2024; 84 doi: 10.1590/1519-6984.284045
|
| 136 |
Ramiro Manzano-Nunez, Marta Santana-Dominguez, Jesus Rivera-Esteban, Clara Sabiote, Elena Sena, Juan Bañares, Frank Tacke, Juan M. Pericàs. Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression. Journal of Clinical Medicine 2023; 12(3) doi: 10.3390/jcm12030856
|
| 137 |
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH). Pharmacology Research & Perspectives 2019; 7(3) doi: 10.1002/prp2.485
|
| 138 |
Thais Carbinatti, Marion Régnier, Lucia Parlati, Fadila Benhamed, Catherine Postic. New insights into the inter-organ crosstalk mediated by ChREBP. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1095440
|
| 139 |
S. Maâlej, S. Jedidi, H. Hannachi, H. Gharsalli, I. Sahnoun, H. Neji, L. El Gharbi. Prévalence et facteurs de risque de stéatose hépatique chez les adultes tunisiens atteints de syndrome d’apnées hypopnées obstructives du sommeil. Revue des Maladies Respiratoires 2020; 37(1) doi: 10.1016/j.rmr.2019.11.643
|
| 140 |
Shudi Li, Fei Duan, Suling Li, Baoping Lu. Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysis. Annals of Hepatology 2024; 29(2) doi: 10.1016/j.aohep.2023.101174
|
| 141 |
Han Wang, Yanjun Jia, Xiaoyan Yu, Li Peng, Chunfeng Mou, Zhixin Song, Dapeng Chen, Xiaoqiang Li, Antonio Molina Carballo. Circulating Prokineticin 2 Levels Are Increased in Children with Obesity and Correlated with Insulin Resistance. International Journal of Endocrinology 2021; 2021 doi: 10.1155/2021/6630102
|
| 142 |
Esteban Porrini, Maruja Navarro-Díaz, Rosa Rodríguez-Rodríguez, Eduardo Salido. Diabetic Nephropathy. 2019; doi: 10.1007/978-3-319-93521-8_5
|
| 143 |
Pooja Dudeja, Taishee Pal, Aman Sharma. The novel approach for non-invasive diagnostic biomarkers from an early stage of NAFLD to advanced fibrosis. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00287-3
|
| 144 |
Avner Ehrlich, Sabina Tsytkin-Kirschenzweig, Konstantinos Ioannidis, Muneef Ayyash, Anne Riu, Reine Note, Gladys Ouedraogo, Jan Vanfleteren, Merav Cohen, Yaakov Nahmias. Microphysiological flux balance platform unravels the dynamics of drug induced steatosis. Lab on a Chip 2018; 18(17) doi: 10.1039/C8LC00357B
|
| 145 |
Alessia Di Costanzo, Lucia Pacifico, Laura D’Erasmo, Luca Polito, Michele Di Martino, Francesco Massimo Perla, Ludovica Iezzi, Claudio Chiesa, Marcello Arca. Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children. International Journal of Molecular Sciences 2019; 20(18) doi: 10.3390/ijms20184444
|
| 146 |
Sabine Gufler, Rita Seeboeck, Christoph Schatz, Johannes Haybaeck. The Translational Bridge between Inflammation and Hepatocarcinogenesis. Cells 2022; 11(3) doi: 10.3390/cells11030533
|
| 147 |
MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regression. Diabetes Research and Clinical Practice 2021; 178 doi: 10.1016/j.diabres.2021.108951
|
| 148 |
Cameron J. Herting, Gregory B. Lesinski. Immune Strategies for Gastrointestinal Cancer. Cancer Immunotherapy 2021; 2 doi: 10.1007/13905_2021_1
|
| 149 |
Chunfeng Mou, Shan Liu, Yetao Luo, Yu Xue, Jia Liu, Dapeng Chen, Xiaoqiang Li, Han Wang. Ependymin‐related protein 1 levels are elevated in children with obesity and correlated with metabolic disorders. Pediatric Discovery 2024; 2(1) doi: 10.1002/pdi3.25
|
| 150 |
Umesh K. Goand, Inklisan Patel, Saurabh Verma, Shubhi Yadav, Debalina Maity, Naveen Singh, Sachin Vishwakarma, Shivam Rathaur, Richa Garg, Jiaur R. Gayen. Immunometabolic impact of pancreastatin inhibitor PSTi8 in MCD induced mouse model of oxidative stress and steatohepatitis. Cytokine 2023; 171 doi: 10.1016/j.cyto.2023.156354
|
| 151 |
Isabel Hidalgo, Nayelli Nájera, Eduardo Meaney, Javier Pérez-Durán, Yolotzin Valdespino-Vazquez, Francisco Villarreal, Guillermo Ceballos. Effects of (−)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis. The Journal of Nutritional Biochemistry 2020; 77 doi: 10.1016/j.jnutbio.2019.108296
|
| 152 |
C. Pieterman, J. Jiang, M. Gerards, G. Ertaylan, R. Peeters, T. de Kok. P12-49 Finding the roadmap of a liver cell developing non-alcoholic fatty liver disease. Toxicology Letters 2022; 368 doi: 10.1016/j.toxlet.2022.07.528
|
| 153 |
Fatemeh Dashti, Seyed Moayed Alavian, Amir Ali Sohrabpour, Sara Ebrahimi Mousavi, Seyed-Ali Keshavarz, Ahmad Esmaillzadeh. Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial. BMJ Open 2023; 13(4) doi: 10.1136/bmjopen-2022-063988
|
| 154 |
Iván A. González, Dhanpat Jain. Diagnosis and classification of vascular liver disorders. Diagnostic Histopathology 2023; 29(1) doi: 10.1016/j.mpdhp.2022.10.005
|
| 155 |
Wei Li, Beverly Spray, Elisabet Børsheim, Soheila Korourian, Reza Hakkak. Long-Term Feeding Soy Protein Concentrates Protect Against Hepatic Steatosis Independent of Isoflavone Levels. Journal of Medicinal Food 2023; 26(12) doi: 10.1089/jmf.2023.0118
|
| 156 |
Patrick C. Turnbull, Ali C. Dehghani, Christopher F. Theriau, Michael K. Connor, Christopher G. R. Perry. Synergistic activation of mitochondrial metabolism and the glutathione redox couple protects HepG2 hepatocarcinoma cells from palmitoylcarnitine-induced stress. American Journal of Physiology-Cell Physiology 2019; 317(6) doi: 10.1152/ajpcell.00366.2019
|
| 157 |
Yong Du, Laura Paglicawan, Sanam Soomro, Omar Abunofal, Sahar Baig, Kamala Vanarsa, John Hicks, Chandra Mohan. Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization. Nutrients 2021; 13(2) doi: 10.3390/nu13020599
|
| 158 |
Ludivine Renaud, Willian A. da Silveira, E. Starr Hazard, Jonathan Simpson, Silvia Falcinelli, Dongjun Chung, Oliana Carnevali, Gary Hardiman. The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNome. Genes 2017; 8(10) doi: 10.3390/genes8100269
|
| 159 |
Mirah Khalid Alshehhi, Asiya Nazir. Microbiome Therapeutics. 2023; doi: 10.1016/B978-0-323-99336-4.00010-0
|
| 160 |
Yu-Tsen Hsieh, Tung-Hsuan Kang, Hsin-Yi Hung, Yi-Han Chang, Kuan-Chen Cheng, Chia-Yih Wang, Wen-Tai Chiu, Pai-Sheng Chen, Shih-Chieh Lin, I-Chen Peng. Identification of a 2-phenoxychromone derivative as a novel inhibitor of lipid droplet formation in hepatocytes and adipocytes. Results in Chemistry 2025; 16 doi: 10.1016/j.rechem.2025.102389
|
| 161 |
Ioannis Katsaros, Maria Sotiropoulou, Michail Vailas, Fotini Papachristou, Paraskevi Papakyriakopoulou, Marirena Grigoriou, Nikolaos Kostomitsopoulos, Alexandra Giatromanolaki, Georgia Valsami, Alexandra Tsaroucha, Dimitrios Schizas. The Effect of Quercetin on Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Beclin1, P62, and LC3: An Experimental Study. Nutrients 2024; 16(24) doi: 10.3390/nu16244282
|
| 162 |
Ying Wang, Chaojie Chen, Jiajun Chen, Tingting Sang, He Peng, Xiaojian Lin, Qian Zhao, Shengjia Chen, Thomas Eling, Xingya Wang. Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation. Redox Biology 2022; 52 doi: 10.1016/j.redox.2022.102322
|
| 163 |
Doaa El Amrousy, Dalia El-Afify, Esraa Abd Al-Fattah Sorour, Shymaa Elrifaey. Effect of Lactoferrin in Obese Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Disease: A Randomized Controlled Study. Pediatric Drugs 2026; 28(3) doi: 10.1007/s40272-026-00742-9
|
| 164 |
Prabhakar Yellanur Konda, Vijayakumar Poondla, Krishna Kumar Jaiswal, Sreenivasulu Dasari, Reddemma Uyyala, Venkata Prasad Surtineni, Janardhan Yadav Egi, Anthony Johnson Antony Masilamani, Lakshmi Bestha, Sreenath Konanki, Muthukumaran Muthulingam, Lakshman Kumar Lingamgunta, Bindu Prasuna Aloor, Sridevi Tirumalaraju, Ankanna Sade, Venkata Ratnam Kamsala, Sreeharsha Nagaraja, Ranjani Ramakrishnan, Vijayakumar Natesan. Pathophysiology of high fat diet induced obesity: impact of probiotic banana juice on obesity associated complications and hepatosteatosis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-73670-4
|
| 165 |
Hafiz Muhammad Umer Farooqi, Anupamma Sammantasinghar, Farzana Kausar, Muhammad Awais Farooqi, Abdul Rahim Chethikkattuveli Salih, Kinam Hyun, Jong-Hwan Lim, Atif Ali Khan Khalil, Abdul Samad Mumtaz, Kyung Hyun Choi. Study of the Anticancer Potential of Plant Extracts Using Liver Tumor Microphysiological System. Life 2022; 12(2) doi: 10.3390/life12020135
|
| 166 |
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseases. Phytotherapy Research 2020; 34(6) doi: 10.1002/ptr.6598
|
| 167 |
N.A. Rajesh, L. Drishya, Murali Mohan Raju Ambati, Athi L. Narayanan, Maria Alex, Kiran Kumar R, Justin J. Abraham, T.M. Vijayakumar. Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia—A Prospective, Interventional, Pilot Study. Journal of Clinical and Experimental Hepatology 2022; 12(1) doi: 10.1016/j.jceh.2021.03.012
|
| 168 |
Mehmed Abtulov, Stefka Valcheva-Kuzmanova. Beneficial effects of polyphenols in metabolic syndrome—a review. Scripta Scientifica Medica 2021; 53(3) doi: 10.14748/ssm.v0i0.7578
|
| 169 |
Angelique M. L. Scantlebery, Peter Ochodnicky, Lotte Kors, Elena Rampanelli, Loes M. Butter, Chaima El Boumashouli, Nike Claessen, Gwen J. Teske, Marius A. van den Bergh Weerman, Jaklien C. Leemans, Joris J. T. H. Roelofs, Sandrine Florquin. β-Cyclodextrin counteracts obesity in Western diet-fed mice but elicits a nephrotoxic effect. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53890-z
|
| 170 |
Letícia Fernandes Gomes, Sibelle Aparecida Madureira Costa, Arthur Rocha-Gomes, Amanda Escobar Teixeira, Alexandre Alves da Silva, Mayara Rodrigues Lessa, Nísia Andrade Villela Dessimoni-Pinto, Sergio Ricardo Stuckert Seixas, Tania Regina Riul. Cafeteria diet from birth to adulthood promotes hepatic steatosis and redox imbalance in Wistar rats. Nutrition & Food Science
2021; 51(3) doi: 10.1108/NFS-05-2020-0191
|
| 171 |
Zhengxi Chen, Holly Hartman, Abhishek Deshpande. Prevalence and Trends of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease among Adults in the United States. Southern Medical Journal 2026; 119(1) doi: 10.14423/SMJ.0000000000001924
|
| 172 |
Yana Sandlers, Rohan R. Shah, Ryan W. Pearce, Jaividhya Dasarathy, Arthur J. McCullough, Srinivasan Dasarathy. Plasma Krebs Cycle Intermediates in Nonalcoholic Fatty Liver Disease. Journal of Clinical Medicine 2020; 9(2) doi: 10.3390/jcm9020314
|
| 173 |
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Sabina Evan Prince. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells 2022; 11(24) doi: 10.3390/cells11243959
|
| 174 |
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. Expert Review of Gastroenterology & Hepatology 2019; 13(5) doi: 10.1080/17474124.2019.1595589
|
| 175 |
Pei Xuan Song, Juan Peng, Mohyeddine Omrane, Ting ting Cai, Didier Samuel, Ama Gassama-Diagne. Septin 9 and phosphoinositides regulate lysosome localization and their association with lipid droplets. iScience 2022; 25(5) doi: 10.1016/j.isci.2022.104288
|
| 176 |
Aleksandra Leszczynska, Thibault Alle, Benedikt Kaufmann, Hana Sung, Christian Stoess, Agustina Reca, Andrea Kim, Sun Kim, Chelsea Tran, Killian Oukoloff, Ludovica Monti, Bobby Lucero, Ilya Gertsman, Jeremiah D. Momper, Phillipp Hartmann, Ariel E. Feldstein, Ranjan Dohil, Carlo Ballatore. d4-Cystamine: A Deuterated Cystamine Derivative with Improved Anti-Inflammatory and Anti-Fibrotic Activities in a Murine Model of Fibrosing Steatohepatitis. ACS Pharmacology & Translational Science 2025; 8(3) doi: 10.1021/acsptsci.4c00738
|
| 177 |
SHIKHA SRIVASTAVA, ZEBA SIDDIQI, TARUNA SINGH, LAKSHMI BALA. Beetroot Supplementation on Non - Alcoholic Fatty Liver Disease Patients. Current Research in Nutrition and Food Science Journal 2019; 7(1) doi: 10.12944/CRNFSJ.7.1.10
|
| 178 |
Daniela Maria Tanase, Evelina Maria Gosav, Claudia Florida Costea, Manuela Ciocoiu, Cristina Mihaela Lacatusu, Minela Aida Maranduca, Anca Ouatu, Mariana Floria. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). Journal of Diabetes Research 2020; 2020 doi: 10.1155/2020/3920196
|
| 179 |
Rubén Peña-Vélez, Nayely Garibay-Nieto, Manuel Cal-y-Mayor-Villalobos, Estibalitz Laresgoiti-Servitje, Karen Pedraza-Escudero, María del Carmen García-Blanco, Omar Alfonso Heredia-Nieto, Eréndira Villanueva-Ortega. Association between neck circumference and non-alcoholic fatty liver disease in Mexican children and adolescents with obesity. Journal of Pediatric Endocrinology and Metabolism 2020; 33(2) doi: 10.1515/jpem-2019-0204
|
| 180 |
Kwazikwakhe B. Gabuza, Ntandoyenkosi Buthelezi, Abidemi Paul Kappo, Thendo I. Mabuda, Rebamang Mosa, Johan Louw, Christo J.F. Muller. In vitro and in vivo hepatotoxicity study of Afriplex™ GRT through an inflammatory response. Toxicology Reports 2022; 9 doi: 10.1016/j.toxrep.2022.10.006
|
| 181 |
Somayeh Rostami, Sara Arefhosseini, Helda Tutunchi, Manouchehr Khoshbaten, Mehrangiz Ebrahimi‐Mameghani. Does myo‐inositol supplementation influence oxidative stress biomarkers in patients with non‐alcoholic fatty liver disease?. Food Science & Nutrition 2024; 12(2) doi: 10.1002/fsn3.3842
|
| 182 |
Harshul Pandit, Joseph P. Tinney, Yan Li, Guozhen Cui, Suping Li, Bradley B. Keller, Robert C.G. Martin. Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse Models. Ultrasound in Medicine & Biology 2019; 45(2) doi: 10.1016/j.ultrasmedbio.2018.10.011
|
| 183 |
Ye Eun Cho, Yong Seong Kwon, Seonghwan Hwang. Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease. Liver Research 2023; 7(1) doi: 10.1016/j.livres.2022.06.001
|
| 184 |
Chih‐Yuan Ko, Yangming Martin Lo, Jian‐Hua Xu, Wen‐Chang Chang, Da‐Wei Huang, James Swi‐Bea Wu, Cho‐Hua Yang, Wen‐Chung Huang, Szu‐Chuan Shen. Alpha‐lipoic acid alleviates NAFLD and triglyceride accumulation in liver via modulating hepatic NLRP3 inflammasome activation pathway in type 2 diabetic rats. Food Science & Nutrition 2021; 9(5) doi: 10.1002/fsn3.2235
|
| 185 |
Ju-Yeon Kim, Haena Choi, Hyeon-Ji Kim, Yelin Jee, Minsoo Noh, Mi-Ock Lee. Polyploidization of Hepatocytes: Insights into the Pathogenesis of Liver Diseases. Biomolecules & Therapeutics 2022; 30(5) doi: 10.4062/biomolther.2022.070
|
| 186 |
Annalisa Curcio, Adriana Romano, Simona Cuozzo, Antonio Di Nicola, Orazio Grassi, Donatella Schiaroli, Giuseppe Fabrizio Nocera, Michele Pironti. Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD Patients. Medicina 2020; 56(10) doi: 10.3390/medicina56100544
|
| 187 |
Zeynab Yousefi, Mitra Nourbakhsh, Zohreh Abdolvahabi, Seyedeh‐Sara Ghorbanhosseini, Zahra Hesari, Sahar Yarahmadi, Samira Ezzati‐Mobasser, Parvane Seiri, Mohammad Borji, Reza Meshkani, Mojtaba Malek. microRNA‐141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP‐activated protein kinase pathway in hepatocytes. Journal of Cellular Physiology 2020; 235(2) doi: 10.1002/jcp.29002
|
| 188 |
Julie Rask Larsen, Lorena Dima, Christoph U. Correll, Peter Manu. The pharmacological management of metabolic syndrome. Expert Review of Clinical Pharmacology 2018; 11(4) doi: 10.1080/17512433.2018.1429910
|
| 189 |
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. International Journal of Environmental Research and Public Health 2020; 17(10) doi: 10.3390/ijerph17103518
|
| 190 |
A.K. Sahu, A. Upadhyay, H. Bhakuni, A.M.H.S. Attanayake, P. Sharma. Effect of Ayurveda interventions in non-alcoholic grade II fatty liver associated with obesity – A case report. Journal of Ayurveda and Integrative Medicine 2022; 13(3) doi: 10.1016/j.jaim.2022.100605
|
| 191 |
Andrea Pasta, Elena Formisano, Francesco Calabrese, Elisa Marabotto, Manuele Furnari, Giorgia Bodini, Maria Corina Plaz Torres, Livia Pisciotta, Edoardo Giovanni Giannini, Patrizia Zentilin. From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease. Microorganisms 2025; 13(2) doi: 10.3390/microorganisms13020241
|
| 192 |
Luo Yang, Xiang Zhang, Min Liao, Yarong Hao. RETRACTED: Echinacoside improves diabetic liver injury by regulating the AMPK/SIRT1 signaling pathway in db/db mice. Life Sciences 2021; 271 doi: 10.1016/j.lfs.2021.119237
|
| 193 |
Julia Coelho Moura, Vincent S Gallicchio. The Clinical Use of Stem Cells in Liver Cancer Treatment: Interactions Between Diet, Metabolic Disease and Hepatic Regeneration. Journal of Regenerative Medicine and Biology Research 2026; 7(2) doi: 10.46889/JRMBR.2026.7204
|
| 194 |
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Reports 2021; 36(3) doi: 10.1016/j.celrep.2021.109393
|
| 195 |
Katherine Rodriguez, Ashley Cast, Nikolai A. Timchenko. Correction of aging phenotype in the liver. Aging 2018; 10(8) doi: 10.18632/aging.101523
|
| 196 |
Yeon-Ji Kim, Ki Mo Kim, Seung-Hyung Kim, Sanghyun Lee, Jin Won Hyun, Ki-Shuk Shim, Taesoo Kim, Kyungho Kim, Sungwook Chae, Anupama Bose. Antilipogenic Effect of Cirsium japonicum var. maackii According to Harvest Time and Plant Part in High‐Fat Diet‐Induced Nonalcoholic Fatty Liver Disease. Journal of Food Biochemistry 2026; 2026(1) doi: 10.1155/jfbc/3260026
|
| 197 |
Laura Colombo. A Survey Assessing Nonalcoholic Fatty Liver Disease Knowledge Among Hepatologists and Non‐Hepatologists in China. JGH Open 2024; 8(12) doi: 10.1002/jgh3.70054
|
| 198 |
Yunjie Liao, Nathan A. Davies, I. David L. Bogle. A process systems Engineering approach to analysis of fructose consumption in the liver system and consequences for Non-Alcoholic fatty liver disease. Chemical Engineering Science 2022; 263 doi: 10.1016/j.ces.2022.118131
|
| 199 |
Cíntia Castro-Correia, Rita Santos-Silva, Marta Pinheiro, Carla Costa, Manuel Fontoura. Metabolic risk factors in adolescent girls with type 1 diabetes. Journal of Pediatric Endocrinology and Metabolism 2018; 31(6) doi: 10.1515/jpem-2018-0053
|
| 200 |
Nilay D. Solanki, Kirti Vadi, Sandip Patel. Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver disease. Indian Journal of Physiology and Pharmacology 2021; 65 doi: 10.25259/IJPP_406_2020
|
| 201 |
A. V. Bogolyubova, E. E. Mishina, P. O. Bogomolov, M. V. Matsievich, K. Yu. Kokina, A. Yu. Mayorov, P. V. Belousov. EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS. Medical Immunology (Russia) 2019; 21(5) doi: 10.15789/1563-0625-2019-5-945-952
|
| 202 |
Xiaolei Zhang, Xueying Shang, Shi Jin, Zhuoqi Ma, He Wang, Na AO, Jing Yang, Jian Du. Vitamin D ameliorates high-fat-diet-induced hepatic injury via inhibiting pyroptosis and alters gut microbiota in rats. Archives of Biochemistry and Biophysics 2021; 705 doi: 10.1016/j.abb.2021.108894
|
| 203 |
David E. Stec, Darren M. Gordon, Jennifer A. Hipp, Stephen Hong, Zachary L. Mitchell, Natalia R. Franco, J. Walker Robison, Christopher D. Anderson, Donald F. Stec, Terry D. Hinds. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2019; 317(5) doi: 10.1152/ajpregu.00153.2019
|
| 204 |
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in Egypt. American Journal of Biochemistry and Molecular Biology 2018; 8(1) doi: 10.3923/ajbmb.2018.16.22
|
| 205 |
Nehal Elmansoury, Ahmed A. Megahed, Ahmed Kamal, Nefertiti El-Nikhely, Marina Labane, Manal Abdelmageed, Ann K. Daly, Ahmed Wahid. Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. Genes 2024; 15(4) doi: 10.3390/genes15040455
|
| 206 |
Tomislav Mašek, Josip Barišić, Vedran Micek, Kristina Starčević. Cafeteria Diet and High-Fructose Rodent Models of NAFLD Differ in the Metabolism of Important PUFA and Palmitoleic Acid without Additional Influence of Sex. Nutrients 2020; 12(11) doi: 10.3390/nu12113339
|
| 207 |
Bo Wang, Yanghua Qu, Yiping Wang, Yong Ma, Chenchen Xu, Fadi Li, Ce Liu, Xiaonan Lu, Bo Wang, Peng Xiu, Yuefeng Gao, Zhicheng Diao, Yuxia Li, Hailing Luo. Triplet Male Lambs Are More Susceptible than Twins to Dietary Soybean Oil–Induced Fatty Liver. The Journal of Nutrition 2019; 149(6) doi: 10.1093/jn/nxz039
|
| 208 |
Linjie Qiu, Bin Kong, Tiantian Kong, Huan Wang. Recent advances in liver‐on‐chips: Design, fabrication, and applications. Smart Medicine 2023; 2(1) doi: 10.1002/SMMD.20220010
|
| 209 |
Yvonne Huber, Jörn M. Schattenberg. Nicht-alkoholische Fettlebererkrankung. 2022; doi: 10.1007/978-3-662-62484-5_1
|
| 210 |
Adryana Cordeiro, Raquel Costa, Nelson Andrade, Cláudia Silva, Natalia Canabrava, Maria João Pena, Ilda Rodrigues, Sara Andrade, Andrea Ramalho. Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?. Clinics and Research in Hepatology and Gastroenterology 2020; 44(4) doi: 10.1016/j.clinre.2019.10.001
|
| 211 |
Eline H. van den Berg, James P. Corsetti, Stephan J. L. Bakker, Robin P. F. Dullaart, Petter Bjornstad. Plasma ApoE elevations are associated with NAFLD: The PREVEND Study. PLOS ONE 2019; 14(8) doi: 10.1371/journal.pone.0220659
|
| 212 |
Ilona Darlyuk-Saadon, Chen Bai, Chew Kiat Matthew Heng, Nechama Gilad, Wei-Ping Yu, Pei Yen Lim, Amaury Cazenave-Gassiot, Yongliang Zhang, W. S. Fred Wong, David Engelberg. Active p38α causes macrovesicular fatty liver in mice. Proceedings of the National Academy of Sciences 2021; 118(14) doi: 10.1073/pnas.2018069118
|
| 213 |
Muhammad Amir, Michael Yu, Peijian He, Shanthi Srinivasan. Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00062
|
| 214 |
Resham Ramkissoon, Timothy B. Gardner. Pancreatic Steatosis: An Emerging Clinical Entity. American Journal of Gastroenterology 2019; 114(11) doi: 10.14309/ajg.0000000000000262
|
| 215 |
Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, Marialuisa Sponziello, Laura D’Erasmo, Licia Polimeni, Francesco Baratta, Daniele Pastori, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Giuseppe Giannini, Maria Del Ben, Francesco Angelico, Marcello Arca. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21939-0
|
| 216 |
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese Patients. Current Hepatology Reports 2017; 16(4) doi: 10.1007/s11901-017-0377-3
|
| 217 |
Yuta Matsubara, Hiroki Kiyohara, Toshiaki Teratani, Yohei Mikami, Takanori Kanai. Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases. Neuropharmacology 2022; 205 doi: 10.1016/j.neuropharm.2021.108915
|
| 218 |
Gary Huang, Daniel F. Wallace, Elizabeth E. Powell, Tony Rahman, Paul J. Clark, V. Nathan Subramaniam. Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics. Biomedicines 2023; 11(10) doi: 10.3390/biomedicines11102809
|
| 219 |
Maria Kalogirou, Emmanouil Sinakos. Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?. World Journal of Hepatology 2018; 10(11): 790-794 doi: 10.4254/wjh.v10.i11.790
|
| 220 |
Anirudh Kohli. Is it important to quantify hepatic fibrosis?. Indian Journal of Radiology and Imaging 2019; 29(04) doi: 10.4103/ijri.IJRI_521_19
|
| 221 |
Courtney D. McGinnis, Erin Q. Jennings, Peter S. Harris, James J. Galligan, Kristofer S. Fritz. Biochemical Mechanisms of Sirtuin-Directed Protein Acylation in Hepatic Pathologies of Mitochondrial Dysfunction. Cells 2022; 11(13) doi: 10.3390/cells11132045
|
| 222 |
Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae. The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 Inhibition. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00539
|
| 223 |
Kuldeep Rajpoot. Role of Artificial Intelligence in Nanomedicine and Organ-specific Therapy: An Updated Review. Current Drug Targets 2025; 26(13) doi: 10.2174/0113894501394785250715165404
|
| 224 |
Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD. Journal of Clinical Medicine 2020; 9(3) doi: 10.3390/jcm9030870
|
| 225 |
Elham Karimi-Sales, Gisou Mohaddes, Mohammad Reza Alipour. Hepatoprotection of capsaicin in alcoholic and non-alcoholic fatty liver diseases. Archives of Physiology and Biochemistry 2024; 130(1) doi: 10.1080/13813455.2021.1962913
|
| 226 |
Qiqin Lu, Majia La, Ziyang Wang, Jiaomei Huang, Jiahui Zhu, Dejun Zhang. Investigation of Active Components of Meconopsis integrifolia (Maxim.) Franch in Mitigating Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 26(1) doi: 10.3390/ijms26010050
|
| 227 |
Muhammad Radzi Abu Hassan, Rosaida Hj Md Said, Zalwani Zainuddin, Haniza Omar, Siti Maisarah Md Ali, Siti Aishah Aris, Huan-Keat Chan. Effects of one-year supplementation with Phyllanthus niruri on fibrosis score and metabolic markers in patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial. Heliyon 2023; 9(6) doi: 10.1016/j.heliyon.2023.e16652
|
| 228 |
Simone Carotti, Katia Aquilano, Francesco Valentini, Sergio Ruggiero, Francesca Alletto, Sergio Morini, Antonio Picardi, Raffaele Antonelli-Incalzi, Daniele Lettieri-Barbato, Umberto Vespasiani-Gentilucci. An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(4) doi: 10.1152/ajpgi.00049.2020
|
| 229 |
Mareca Lodge, Rachel Dykes, Arion Kennedy. Regulation of Fructose Metabolism in Nonalcoholic Fatty Liver Disease. Biomolecules 2024; 14(7) doi: 10.3390/biom14070845
|
| 230 |
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy. Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. Metabolites 2020; 10(7) doi: 10.3390/metabo10070283
|
| 231 |
Bo Yang, Xiang Zhong. Clinical model to predict the risk of nonalcoholic fatty liver disease: A secondary analysis of data from a cross-sectional study. Medicine 2024; 103(36) doi: 10.1097/MD.0000000000039437
|
| 232 |
Mark G. Swain, David E. J. Jones. Fatigue in chronic liver disease: New insights and therapeutic approaches. Liver International 2019; 39(1) doi: 10.1111/liv.13919
|
| 233 |
Camilo Rey-Bedon, Peony Banik, Aslihan Gokaltun, O. Hofheinz, Martin.L. Yarmush, M. Korkut Uygun, O. Berk Usta. CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. Biomedicine & Pharmacotherapy 2022; 146 doi: 10.1016/j.biopha.2021.112377
|
| 234 |
Dey Parama, Sosmitha Girisa, Elina Khatoon, Aviral Kumar, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi, Ajaikumar B. Kunnumakkara. An overview of the pharmacological activities of scopoletin against different chronic diseases. Pharmacological Research 2022; 179 doi: 10.1016/j.phrs.2022.106202
|
| 235 |
Katarzyna Kozłowska-Petriczko, Ewa Wunsch, Jan Petriczko, Wing-Kin Syn, Piotr Milkiewicz. Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference. Journal of Clinical Medicine 2021; 10(7) doi: 10.3390/jcm10071507
|
| 236 |
Lucas Zangerolamo, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Maria Esméria do Amaral, Everardo Magalhães Carneiro, Sara Teresinha Olalla-Saad, Antonio Carlos Boschero, Helena Cristina Barbosa-Sampaio. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese mice. Canadian Journal of Physiology and Pharmacology 2019; 97(11) doi: 10.1139/cjpp-2018-0691
|
| 237 |
Qian Zhang, Kun Yu, Yazhen Cao, Yanli Luo, Yan Liu, Caiyan Zhao. miR-125b promotes the NF-κB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3. Life Sciences 2021; 270 doi: 10.1016/j.lfs.2021.119071
|
| 238 |
Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Kwang-Huei Lin. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma. Cells 2020; 9(2) doi: 10.3390/cells9020262
|
| 239 |
Alina Abdolahi, Zakaria Vahabzadeh, Esmael Izadpanah, Mohammad Raman Moloudi. Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway. Journal of Physiology and Biochemistry 2022; 78(1) doi: 10.1007/s13105-021-00852-7
|
| 240 |
Muhammad Awais Farooqi, Chul-Ung Kang, Kyung Hyun Choi. Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes. ACS Omega 2023; 8(35) doi: 10.1021/acsomega.3c03155
|
| 241 |
Amir Mohammad Kazemifar, Ali Akbar Shafikhani, Elaheh HajiNoormohammadi, Zahra Azarion, Aliakbar Hajiaghamohammadi. Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trial. Egyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0001-z
|
| 242 |
Mohit Mirchandani, Herby Jeanty, Satabdi Sahu, Hessam Nejati, Saisree Reddy Adla Jala, Abinash Mahapatro, Shika M Jain, Amir Nasrollahizadeh, Ghazalgoo Arezoo, Seyyed Mohammad Hashemi, Ehsan Amini-Salehi. Exploring the Systemic Immune-Inflammation Index as a novel biomarker for nonalcoholic fatty liver disease: a systematic review and meta-analysis. Annals of Medicine & Surgery 2025; 87(12) doi: 10.1097/MS9.0000000000004097
|
| 243 |
Aurora Barberá, Imma Raurell, Teresa García‐Lezana, Manuel Torres‐Arauz, Miren Bravo, Diana Hide, Mar Gil, María Teresa Salcedo, Joan Genescà, María Martell, Salvador Augustin. Steatosis as main determinant of portal hypertension through a restriction of hepatic sinusoidal area in a dietary rat nash model. Liver International 2020; 40(11) doi: 10.1111/liv.14632
|
| 244 |
Shenzong Rao, Jingsong Huang, Zhijun Shen, Changgang Xiang, Min Zhang, Xueliang Lu. Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease. Journal of Cellular Biochemistry 2019; 120(7) doi: 10.1002/jcb.28468
|
| 245 |
Dachuan Jin, Shunqin Jin, Tao Zhou, Zhongfeng Cui, Baoqiang Guo, Guangming Li, Chunming Zhang. Regional variation in NAFLD prevalence and risk factors among people living with HIV in Europe: a meta-analysis. Frontiers in Public Health 2024; 11 doi: 10.3389/fpubh.2023.1295165
|
| 246 |
Pankaj Prabhakar, Vijay Marakala, Dhanya Sacheendran, Thomas George, Rhea Katherine D'souza, Princy Louis Palatty, Manjeshwar Shrinath Baliga. Ginger (Zingiber officinale Roscoe; Family: Zingiberaceae) in Non-Alcoholic Fatty Liver Disease: Review on the Existing Scientific Evidence and Way Forward. Current Nutrition & Food Science 2024; 20(7) doi: 10.2174/1573401319666230913122317
|
| 247 |
Mathias Haag, Stefan Winter, Aurino M. Kemas, Julia Tevini, Alexandra Feldman, Sebastian K. Eder, Thomas K. Felder, Christian Datz, Bernhard Paulweber, Gerhard Liebisch, Oliver Burk, Volker M. Lauschke, Elmar Aigner, Matthias Schwab. Circulating metabolite signatures indicate differential gut-liver crosstalk in lean and obese MASLD. JCI Insight 2025; 10(8) doi: 10.1172/jci.insight.180943
|
| 248 |
Cyriac Abby Philips, Philip Augustine, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar, Guruprasad Padsalgi, Pushpa Mahadevan. Acute exacerbated severe form of nonalcoholic steatohepatitis leading to acute-on-chronic liver failure: A case series. Indian Journal of Gastroenterology 2020; 39(1) doi: 10.1007/s12664-020-01028-9
|
| 249 |
Diego Nocetti, Alejandra Espinosa, Francisco Pino-De la Fuente, Camila Sacristán, José Luis Bucarey, Paulina Ruiz, Rodrigo Valenzuela, Raphaël Chouinard-Watkins, Inés Pepper, Rodrigo Troncoso, Luis Puente. Lipid droplets are both highly oxidized and Plin2-covered in hepatocytes of diet-induced obese mice. Applied Physiology, Nutrition, and Metabolism 2020; 45(12) doi: 10.1139/apnm-2019-0966
|
| 250 |
Mayank Handa, Vanshul Saini, Shourya Tripathi, Awesh Yadav, Rahul Shukla. Nanomaterial-Based Drug Delivery Systems. 2023; doi: 10.1007/978-3-031-30529-0_5
|
| 251 |
Feryal Savari, Seyed Ali Mard. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment. Heliyon 2024; 10(7) doi: 10.1016/j.heliyon.2024.e28468
|
| 252 |
Emir Tas, Divya Sundararajan, Jaclyn S Lo, Nazeen Morelli, Yesenia Garcia-Reyes, Meredith A Ware, Haseeb Rahat, Xiawei Ou, Xiaoxu Na, Shikha Sundaram, Cameron Severn, Laura L Pyle, Elisabet Børsheim, Mary Ellen Vajravelu, Radhika Muzumdar, Jonathan A Dranoff, Melanie G Cree. Diagnostic Accuracy of Transient Elastography in Hepatosteatosis in Youth With Obesity. Journal of the Endocrine Society 2024; 8(7) doi: 10.1210/jendso/bvae110
|
| 253 |
Huili Yang, Lian Feng, Linyi Xu, Dansheng Jiang, Fenfen Zhai, Guangdong Tong, Yufeng Xing, Koichiro Wada. Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut‐Liver Axis. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/4801695
|
| 254 |
Gayathri V K, K V Pradeep. A LITERARY REVIEW OF NON-ALCOHOLIC FATTY LIVER DISEASE W.S.R. SANTARPANAJANYA VYADHI. International Ayurvedic Medical Journal 2024; 12(11) doi: 10.46607/iamj1312112024
|
| 255 |
Sou Hyun Kim, Chawon Yun, Doyoung Kwon, Yun-Hee Lee, Jae-Hwan Kwak, Young-Suk Jung. Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells. Molecules 2023; 28(3) doi: 10.3390/molecules28031476
|
| 256 |
Hang Chen, Minshan Huang, Dan Zhang, Hui Wang, Da Wang, Mengwei Li, Xianmei Wang, Rui Zhu, Jianjun Liu, Lanqing Ma. Metformin’s effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1477212
|
| 257 |
Tapan Behl, Ishnoor Kaur, Aayush Sehgal, Sukhbir Singh, Gokhan Zengin, Nicoleta Negrut, Delia Carmen Nistor-Cseppento, Flavia Maria Pavel, Raluca Anca Corb Aron, Simona Bungau. Exploring the Genetic Conception of Obesity via the Dual Role of FoxO. International Journal of Molecular Sciences 2021; 22(6) doi: 10.3390/ijms22063179
|
| 258 |
Manash Pratim Pathak, Kalyani Pathak, Riya Saikia, Urvashee Gogoi, Pompy Patowary, Pronobesh Chattopadhyay, Aparoop Das. Therapeutic potential of bioactive phytoconstituents found in fruits in the treatment of non-alcoholic fatty liver disease: A comprehensive review. Heliyon 2023; 9(4) doi: 10.1016/j.heliyon.2023.e15347
|
| 259 |
Imran Nazir Salroo, Musharaf Bashir, Rayees Ahmad Bhat, Sheikh Imran Sayeed, Nazir Ahmad Salroo. Correlates of ultrasound diagnosed non alcoholic fatty liver disease in Indian adults with features of metabolic syndrome. Journal of Clinical Medicine of Kazakhstan 2020; 1(55) doi: 10.23950/1812-2892-JCMK-00732
|
| 260 |
Sarah Da Won Bae, Jacob George, Liang Qiao. From MAFLD to hepatocellular carcinoma and everything in between. Chinese Medical Journal 2022; 135(5) doi: 10.1097/CM9.0000000000002089
|
| 261 |
Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber Salter, Allan Tsung, Jaquelyn Fleckenstein, Anup S. Shetty, Amir A. Borhani, Alessandro Furlan, Kathryn J. Fowler. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria. HPB 2019; 21(12) doi: 10.1016/j.hpb.2019.04.007
|
| 262 |
Martín Alonso Gómez Zuleta, Oscar Fernando Ruíz Morales, Eddy Johanna Buitrago Laguado. Utilidad del índice de fibrosis hepática (IFH) medido durante la ultrasonografía endoscópica en la evaluación del parénquima pancreático. Revista colombiana de Gastroenterología 2022; 37(1) doi: 10.22516/25007440.644
|
| 263 |
M. Serdarova, R. Dimova, N. Chakarova, G. Grozeva, A. Todorova, P. Tsarkova, C. Marinova, D. Popov, L. Mateva, T. Tankova. Metabolic determinants of NAFLD in adults with type 1 diabetes. Diabetes Research and Clinical Practice 2022; 186 doi: 10.1016/j.diabres.2022.109819
|
| 264 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1) doi: 10.2174/1574885518666230417111247
|
| 265 |
Yi-Hsien Chang, Ya-Ling Chen, Wen-Chung Huang, Chian-Jiun Liou. Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway. Biochemical and Biophysical Research Communications 2018; 495(1) doi: 10.1016/j.bbrc.2017.11.022
|
| 266 |
Zahaan Vakil, Kiran Ahire. Clinical Profile of Nonalcoholic Fatty Liver Disease and its Correlation with Metabolic Syndrome and Cardiovascular Risk. International Journal of Applied & Basic Medical Research 2023; 13(4) doi: 10.4103/ijabmr.ijabmr_138_23
|
| 267 |
Lisa Morisseau, Françoise Gilard, Bertrand Gakière, Cécile Legallais, Yasuyuki Sakai, Eric Leclerc, Rachid Jellali. Metabolomic profiling of HepG2/C3A liver-on-chip model exposed to oleic acid, palmitic acid and oleic/palmitic acids mixture. NAM Journal 2026; doi: 10.1016/j.namjnl.2026.100122
|
| 268 |
Nikhil Makhija, Naval K. Vikram, Deep N. Srivastava, Kumble S. Madhusudhan. Role of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis and Grading of Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease: Comparison With Ultrasonography and Magnetic Resonance Spectroscopy. Journal of Clinical and Experimental Hepatology 2021; 11(6) doi: 10.1016/j.jceh.2021.02.008
|
| 269 |
Cristina Oana Mărginean, Lorena Elena Meliț, Maria Oana Săsăran. Metabolic Associated Fatty Liver Disease in Children—From Atomistic to Holistic. Biomedicines 2021; 9(12) doi: 10.3390/biomedicines9121866
|
| 270 |
Yao Teng, Zixuan Zhao, Farah Tasnim, Xiaozhong Huang, Hanry Yu. A scalable and sensitive steatosis chip with long-term perfusion of in situ differentiated HepaRG organoids. Biomaterials 2021; 275 doi: 10.1016/j.biomaterials.2021.120904
|
| 271 |
Dragoș Constantin Cucoranu, Marian Pop, Raluca Niculescu, Vlad Vunvulea, Irina-Bianca Kosovski, Radu-Ovidiu Togănel, Eliza Russu, Adrian Vasile Mureșan, Răzvan-Andrei Licu, Anca Bacârea. Correlation between CT Abdominal Anthropometric Measurements and Liver Density in Individuals with Non-Alcoholic Fatty Liver Disease. Medicina 2023; 59(3) doi: 10.3390/medicina59030500
|
| 272 |
Sarah Esmaeilpour, Farshad Sheikhesmaili, Mohammad Moradzad, Bijan Noori, Mohammad Abdi, Zakaria Vahabzadeh. The diagnostic value of miRNAs combination for Kurdish NAFLD patients. Advances in Biomarker Sciences and Technology 2025; 7 doi: 10.1016/j.abst.2025.11.004
|
| 273 |
Jeong-An Gim, Soo Min Bang, Young-Sun Lee, Yoonseok Lee, Sun Young Yim, Young Kul Jung, Hayeon Kim, Baek-Hui Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun, Matias A. Avila. Evaluation of the severity of nonalcoholic fatty liver disease through analysis of serum exosomal miRNA expression. PLOS ONE 2021; 16(8) doi: 10.1371/journal.pone.0255822
|
| 274 |
Rose Ghemrawi, Shyue-Fang Battaglia-Hsu, Carole Arnold. Endoplasmic Reticulum Stress in Metabolic Disorders. Cells 2018; 7(6) doi: 10.3390/cells7060063
|
| 275 |
Hwa-Young Lee, Geum-Hwa Lee, Young Yoon, Han-Jung Chae. Rhus verniciflua and Eucommia ulmoides Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK Activation. The American Journal of Chinese Medicine 2019; 47(06) doi: 10.1142/S0192415X19500642
|
| 276 |
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, Jae-Jung Shim, Junghyun Lim, Joo-Yun Kim, Jung-Lyoul Lee. Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model. Microorganisms 2023; 11(10) doi: 10.3390/microorganisms11102466
|
| 277 |
Adriely de Brito Silva, Mauro Junior de Brito Farias, Graciella Sales Nascimento, Rafaella Cristiny da Silva Cavalcante, Kennedy Maia dos Santos, Emerson Silva Lima, Ruth Silva Lima da Costa, Antônio Clodoaldo Melo de Castro, Carolina Freitas da Silva, Jader de Andrade Bezerra, Anibal Moteiro de Magalhães-Neto, Cláudia Marlise Balbinotti Andrade, Luiz Carlos de Abreu, João Rafael Valentin Silva, Joy Braga Cavalcante, Luis Carlos Oliveira Gonçalves, Romeu Paulo Martins Silva. Brazilian Amazonian Jatobá sap (Hymenaea Courbaril L.) as a hormonal modulator in soccer athletes. Journal of Human Sport and Exercise 2025; 21(1) doi: 10.55860/s46b4p14
|
| 278 |
Sunni Chen, Siyan Che, Shiqi Li, Zheng Ruan. The combined impact of decabromodiphenyl ether and high fat exposure on non-alcoholic fatty liver disease in vivo and in vitro. Toxicology 2021; 464 doi: 10.1016/j.tox.2021.153015
|
| 279 |
Jarosław Jerzy Sak, Andrzej Prystupa, Paweł Kiciński, Dorota Luchowska-Kocot, Ewa Kurys-Denis, Hanna Bis-Wencel. Leukocyte cell-derived chemotaxin-2 and fibroblast growth factor 21 in alcohol-induced liver cirrhosis. World Journal of Hepatology 2021; 13(12): 2071-2080 doi: 10.4254/wjh.v13.i12.2071
|
| 280 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. Revista de Gastroenterología de México (English Edition) 2021; 86(2) doi: 10.1016/j.rgmxen.2020.04.008
|
| 281 |
Gregory Simchick, Diego Hernando. Optimized acquisition for simultaneous intravoxel incoherent motion and R2 quantification in the liver. Magnetic Resonance in Medicine 2025; 94(6) doi: 10.1002/mrm.70005
|
| 282 |
O. B. Nemchaninova, E. Yu. Sklyanova, S. G. Lykova, E. N. Makhnovets, O. N. Pozdnyakova, T. B. Reshetnikova, A. A. Khryanin. Comorbidity: non-alcoholic fatty liver disease and psoriasis. Experimental and Clinical Gastroenterology 2021; (10) doi: 10.31146/1682-8658-ecg-194-10-55-60
|
| 283 |
Jinsoo Song, In-Jeoung Baek, Sujeong Park, Jinjoo Oh, Deokha Kim, Kyung Song, Mi Kyung Kim, Hye Won Lee, Byoung Kuk Jang, Eun-Jung Jin. Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes. iScience 2022; 25(10) doi: 10.1016/j.isci.2022.105135
|
| 284 |
Ivan P. Gorlov, Olga Y. Gorlova, Aaron P. Thrift, Nobuyuki Takahashi. Differences in gene expression may contribute to the racial differences in the risk of MASLD. PLOS One 2026; 21(5) doi: 10.1371/journal.pone.0345383
|
| 285 |
Shanmugam Murugaiha Jeyakumar, Ayyalasomayajula Vajreswari. Stearoyl-CoA desaturase 1: A potential target for non-alcoholic fatty liver disease?-perspective on emerging experimental evidence. World Journal of Hepatology 2022; 14(1): 168-179 doi: 10.4254/wjh.v14.i1.168
|
| 286 |
Sreenath Kundimi, Krishna Chaitanya Kavungala, Swaraj Sinha, Venkata Narasimha Rao Tayi, Nagendra Rao Kundurthi, Trimurtulu Golakoti, Barbara Davis, Krishanu Sengupta. Combined extracts of Moringa oleifera, Murraya koeingii leaves, and Curcuma longa rhizome increases energy expenditure and controls obesity in high-fat diet-fed rats. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01376-7
|
| 287 |
Seoung-Woo Lee, Su-Min Baek, Kyung-Ku Kang, A-Rang Lee, Tae-Un Kim, Seong-Kyoon Choi, Yoon-Seok Roh, Il-Hwa Hong, Sang-Joon Park, Tae-Hwan Kim, Kyu-Shik Jeong, Jin-Kyu Park. Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease Progression through Impaired de Novo Lipogenesis. The American Journal of Pathology 2021; 191(9) doi: 10.1016/j.ajpath.2021.05.020
|
| 288 |
Michelle L. Parker, Khosrow Adeli, Émile Lévy, Edgard Delvin. Are universal upper reference limits for alanine aminotransferase (ALT) appropriate for assessing pediatric liver injury?. Clinical Biochemistry 2018; 53 doi: 10.1016/j.clinbiochem.2018.01.010
|
| 289 |
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical Applications. Diagnostics 2021; 11(5) doi: 10.3390/diagnostics11050842
|
| 290 |
Huailin Deng, Ruiqiu Zhang. TCM-Derived Natural Compounds Targeting the Gut Microbiota in Metabolic Dysfunction-Associated Steatotic Liver Disease: Gut–Liver Axis Mechanisms, Safety Considerations, and Translational Challenges. Metabolites 2026; 16(5) doi: 10.3390/metabo16050342
|
| 291 |
Jannatul Efte Ekra, Pulak Kanti Palit, Mohammed Mehadi Hassan Chowdhury, Israt Jahan Sourna, Sanzida Islam, Farhana Arefin, Md. Asaduz Zaman, Joyonti Datta, Nafsoon Rahman, Adiba Anjum, Subodh Kumar Sarkar, Ashekul Islam. Metabolic syndrome components as determinants of NAFLD progression in Bangladesh: a cross-sectional study. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00457-5
|
| 292 |
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population. Journal of Clinical and Translational Hepatology 2019; 7(X) doi: 10.14218/JCTH.2019.00010
|
| 293 |
Mark A Anderson, Hamed Kordbacheh, Evita Joseph, Susan E Bennett, Fatima Cody Stanford, Avinash Kambadakone. Computed tomography findings of metabolic syndrome in patients with acute colonic diverticulitis. Journal of Medical Imaging and Radiation Oncology 2021; 65(3) doi: 10.1111/1754-9485.13151
|
| 294 |
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology. 2019; doi: 10.1002/cphy.c190007
|
| 295 |
|
| 296 |
Cong Wang, Shousheng Liu, Linlin Lu, Songling Liao, Haiyan Yue, Quanjiang Dong, Yongning Xin, Shiying Xuan. Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han Population. Hepatitis Monthly 2018; 18(6) doi: 10.5812/hepatmon.66149
|
| 297 |
Hailang Li, Ling Hu, Liwen Wang, Yixuan Wang, Meiqi Shao, Yupei Chen, Wenlin Wu, Lei Wang. Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation. Journal of Agricultural and Food Chemistry 2022; 70(7) doi: 10.1021/acs.jafc.1c06681
|
| 298 |
Hao Qin, Baowen Yuan, Wei Huang, Yan Wang. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.924696
|
| 299 |
M. Zhao, Y. Hu, C. Shi, K. Wang, J. Li, J. Song, C. Huo, Y. Xi, S. Bu, Q. Huang. NFI, a clinical scoring tool for predicting non-alcoholic fatty liver in the Chinese population. Public Health 2022; 202 doi: 10.1016/j.puhe.2021.10.012
|
| 300 |
Avica Atri, Stephen A Jiwanmall, Munaf B Nandyal, Dheeraj Kattula, Sandhiya Paravathareddy, Thomas V Paul, Nihal Thomas, Nitin Kapoor. The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women – A Cross-sectional Study from Southern India. European Endocrinology 2020; 16(2) doi: 10.17925/EE.2020.16.2.152
|
| 301 |
Helda Tutunchi, Farideh Zolrahim, Mahlagha Nikbaf-Shandiz, Fatemeh Naeini, Alireza Ostadrahimi, Sina Naghshi, Reza Salek, Farzad Najafipour. Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1144550
|
| 302 |
Tepparit Samrit, Supawadee Osotprasit, Athit Chaiwichien, Phawiya Suksomboon, Supanan Chansap, Anan Athipornchai, Narin Changklungmoa, Pornanan Kueakhai. Cold-Pressed Sacha Inchi Oil: High in Omega-3 and Prevents Fat Accumulation in the Liver. Pharmaceuticals 2024; 17(2) doi: 10.3390/ph17020220
|
| 303 |
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Intestinal Absorption of Bile Acids in Health and Disease. Comprehensive Physiology 2020; 10(1) doi: 10.1002/j.2040-4603.2020.tb00108.x
|
| 304 |
Yaoxiang Zhu, Ruijue Liu, Zhenglin Shen, Guoqiang Cai. Combination of luteolin and lycopene effectively protect against the “two-hit” in NAFLD through Sirt1/AMPK signal pathway. Life Sciences 2020; 256 doi: 10.1016/j.lfs.2020.117990
|
| 305 |
Giuseppe Guagliano, Cristina Volpini, Lorenzo Sardelli, Francesco Briatico Vangosa, Livia Visai, Paola Petrini. Bioinspired Bioinks for the Fabrication of Chemomechanically Relevant Standalone Disease Models of Hepatic Steatosis. Advanced Healthcare Materials 2024; 13(14) doi: 10.1002/adhm.202303349
|
| 306 |
Vetriselvan Subramaniyan, Srikumar Chakravarthi, Ravindran Jegasothy, Wu Yuan Seng, Neeraj Kumar Fuloria, Shivkanya Fuloria, Iswar Hazarika, Anju Das. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy. Toxicology Reports 2021; 8 doi: 10.1016/j.toxrep.2021.02.010
|
| 307 |
A. L. Loskutov, I. V. Loskutova. INNATE IMMUNITY IN OSTEOARTHRITIS IN COMORBIDITY WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH HELICOBACTER PYLORI INFECTION. World of Medicine and Biology 2021; 17(77) doi: 10.26724/2079-8334-2021-3-77-101-105
|
| 308 |
Mohd Riyazuddin, Arisha Shahid. Non-alcoholic fatty liver disease – discussed under the light of Unani medicine. Journal of Complementary and Integrative Medicine 2023; 20(1) doi: 10.1515/jcim-2021-0296
|
| 309 |
Evangelia S. Makri, Eleftheria Makri, Stergios A. Polyzos. Combination Therapies for Nonalcoholic Fatty Liver Disease. Journal of Personalized Medicine 2022; 12(7) doi: 10.3390/jpm12071166
|
| 310 |
Athina I. Amanatidou, George V. Dedoussis. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease. Computers in Biology and Medicine 2021; 131 doi: 10.1016/j.compbiomed.2021.104243
|
| 311 |
Yousaf Zafar, Ahmed Mustafa Rashid, Ahmed Kamal Siddiqi, Aayat Ellahi, Aymen Ahmed, Hassan ul Hussain, Furqan Ahmed, Ritesh G. Menezes, Tariq Jamal Siddiqi, Muhammad Talha Maniya. Effect of novel glucose lowering agents on non-alcoholic fatty liver disease: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2022; 46(7) doi: 10.1016/j.clinre.2022.101970
|
| 312 |
Guillermo Rus, Inas H. Faris, Jorge Torres, Antonio Callejas, Juan Melchor. Why Are Viscosity and Nonlinearity Bound to Make an Impact in Clinical Elastographic Diagnosis?. Sensors 2020; 20(8) doi: 10.3390/s20082379
|
| 313 |
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 2020; 126(11) doi: 10.1002/cncr.32803
|
| 314 |
Zixiong Zhou, Jing Qi, Chae Woong Lim, Jong-Won Kim, Bumseok Kim. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro. Toxicology 2020; 444 doi: 10.1016/j.tox.2020.152579
|
| 315 |
Venkat R Pannala, Archana Hari, Mohamed Diwan M AbdulHameed, Michele R Balik-Meisner, Deepak Mav, Dhiral P Phadke, Elizabeth H Scholl, Ruchir R Shah, Scott S Auerbach, Anders Wallqvist. Quantifying liver-toxic responses from dose-dependent chemical exposures using a rat genome-scale metabolic model. Toxicological Sciences 2025; doi: 10.1093/toxsci/kfaf005
|
| 316 |
Guy Rostoker, Christelle Loridon, Mireille Griuncelli, Clémentine Rabaté, Fanny Lepeytre, Pablo Ureña-Torres, Belkacem Issad, Nasredine Ghali, Yves Cohen. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study. EBioMedicine 2019; 39 doi: 10.1016/j.ebiom.2018.11.020
|
| 317 |
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse Model. Nutrients 2019; 11(9) doi: 10.3390/nu11092172
|
| 318 |
Reggiani V. Gonçalves, Jamili D.B. Santos, Natanny S. Silva, Etienne Guillocheau, Robson E. Silva, Thaiany G. Souza-Silva, Rafael F. Oliveira, Eliziária C. Santos, Romulo D. Novaes. Trans-fatty acids aggravate anabolic steroid-induced metabolic disturbances and differential gene expression in muscle, pancreas and adipose tissue. Life Sciences 2019; 232 doi: 10.1016/j.lfs.2019.116603
|
| 319 |
Eline H. van den Berg, Eke G. Gruppen, Richard W. James, Stephan J.L. Bakker, Robin P.F. Dullaart. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol. Journal of Lipid Research 2019; 60(1) doi: 10.1194/jlr.P088997
|
| 320 |
Rachelle P. Davis, Bas G. J. Surewaard, Madison Turk, Agostina Carestia, Woo-Yong Lee, Björn Petri, Stefan J. Urbanski, Carla S. Coffin, Craig N. Jenne. Optimization of In vivo Imaging Provides a First Look at Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD) Using Intravital Microscopy. Frontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02988
|
| 321 |
Perizat Kanabekova, Adina Kadyrova, Gulsim Kulsharova. Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro. Micromachines 2022; 13(3) doi: 10.3390/mi13030428
|
| 322 |
Stanislav Konstantinovich Gruzdev, Irina Viktorovna Podoprigora, Oksana Anatolievna Gizinger. Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets. Archives of Microbiology 2024; 206(2) doi: 10.1007/s00203-023-03752-0
|
| 323 |
Arinc Ozturk, Viksit Kumar, Theodore T. Pierce, Qian Li, Masoud Baikpour, Ivan Rosado-Mendez, Michael Wang, Peng Guo, Scott Schoen, Yuyang Gu, Sunethra Dayavansha, Joseph R. Grajo, Anthony E. Samir. The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease. Radiology 2023; 309(2) doi: 10.1148/radiol.223146
|
| 324 |
Bitasta Mandal, Rakesh Das, Sandip Mondal. Anthocyanins: Potential phytochemical candidates for the amelioration of non-alcoholic fatty liver disease. Annales Pharmaceutiques Françaises 2024; 82(3) doi: 10.1016/j.pharma.2024.02.005
|
| 325 |
Tzumei Wang, Chaochun Wei, Jingwen Li, Xinyi Zhao, Kaixuan Wang, Xing Peng, Xiaodong Dou, Yameng Liu, Chao Wang, Ning Jiao. Identification of a novel HNF4α agonist regulating abnormal metabolism. European Journal of Medicinal Chemistry 2026; 314 doi: 10.1016/j.ejmech.2026.118864
|
| 326 |
Maria Esther Rubio-Ruiz, Verónica Guarner-Lans, Agustina Cano-Martínez, Eulises Díaz-Díaz, Linaloe Manzano-Pech, Anel Gamas-Magaña, Vicente Castrejón-Tellez, Concepción Tapia-Cortina, Israel Pérez-Torres. Resveratrol and Quercetin Administration Improves Antioxidant DEFENSES and reduces Fatty Liver in Metabolic Syndrome Rats. Molecules 2019; 24(7) doi: 10.3390/molecules24071297
|
| 327 |
Aleksandra Klisic, Ludovico Abenavoli, Sharmila Fagoonee, Nebojsa Kavaric, Gordana Kocic, Ana Ninić. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score. Minerva Medica 2019; 110(3) doi: 10.23736/S0026-4806.19.05978-0
|
| 328 |
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. Frontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
|
| 329 |
Jerónimo Aragón‐Vela, Antonio J. Sánchez‐Oliver, Jesús R. Huertas, Rafael A. Casuso. Does curcumin improve liver enzymes levels in nonalcoholic fatty liver disease? A systematic review, meta‐analysis, and meta‐regression. Phytotherapy Research 2024; 38(8) doi: 10.1002/ptr.8274
|
| 330 |
Miey Park, Anshul Sharma, Hana Baek, Jin-Young Han, Junho Yu, Hae-Jeung Lee. Stevia and Stevioside Attenuate Liver Steatosis through PPARα-Mediated Lipophagy in db/db Mice Hepatocytes. Antioxidants 2022; 11(12) doi: 10.3390/antiox11122496
|
| 331 |
Subramaniyam Nithyananthan, Dangudubiyyam Sushmaa, Ibansiewdor Myrthong, Lokanatha Valluru, Shreyoshi Guha, Ishfaq Hassan Mir, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Curcuma longaandTrigonella foenum graecum‐enriched nutrient mixture from germinatedMacrotyloma uniflorumandVigna radiateameliorate nonalcoholic fatty liver diseases in rats. Journal of Food Biochemistry 2020; 44(4) doi: 10.1111/jfbc.13159
|
| 332 |
Bahman Rostama, Megan Beauchemin, Celeste Bouchard, Elizabeth Bernier, Calvin P. H. Vary, Meghan May, Karen L. Houseknecht. Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. International Journal of Molecular Sciences 2020; 21(24) doi: 10.3390/ijms21249362
|
| 333 |
Hye In Kim, Jeon-Kyung Kim, Jae-Young Kim, Se-Eun Jang, Myung Joo Han, Dong-Hyun Kim. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in mice. Nutrition Research 2019; 67 doi: 10.1016/j.nutres.2019.03.008
|
| 334 |
Raushan Kumar, Jitendra Kumar Arya, Syed Ibrahim Rizvi. Chitosan reduces inflammation and protects against oxidative stress in a hyperlipidemic rat model: relevance to nonalcoholic fatty liver disease. Molecular Biology Reports 2022; 49(10) doi: 10.1007/s11033-022-07810-6
|
| 335 |
Anup Kumar, Namdev More, Ashish Sharma, Dhanajay Jawade, Gournag Hari Gupta, Aishwarya Balu, Govinda Kapusetti. Ultrahigh Sensitive Graphene Oxide/Conducting Polymer Composite Based Biosensor for Cholesterol and Bilirubin Detection. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4182086
|
| 336 |
Suellen Alves De Azevedo, Ana Clara Xavier Costa, Kelvy Araujo de Sousa Rego, Fernando da Silva Oliveira, Jhennyfer Barbosa de Oliveira Mantesso, Gabriel Mota Paiva, Arissane de Sousa Falcão, Maria Simone Pereira Maciel Mignoni. EFEITOS DAS TERAPIAS NUTRICIONAIS NO DESENVOLVIMENTO E TRATAMENTO DA DOENÇA HEPÁTICA GORDUROSA NÃO ALCOÓLICA. ARACÊ 2025; 7(11) doi: 10.56238/arev7n11-266
|
| 337 |
Oana Craciunescu, Ana-Maria Seciu-Grama, Elena Mihai, Elena Utoiu, Ticuta Negreanu-Pirjol, Carmen Elena Lupu, Victoria Artem, Aurora Ranca, Bogdan-Stefan Negreanu-Pirjol. The Chemical Profile, Antioxidant, and Anti-Lipid Droplet Activity of Fluid Extracts from Romanian Cultivars of Haskap Berries, Bitter Cherries, and Red Grape Pomace for the Management of Liver Steatosis. International Journal of Molecular Sciences 2023; 24(23) doi: 10.3390/ijms242316849
|
| 338 |
Karilyn E. Sant, Hadley M. Moreau, Larissa M. Williams, Haydee M. Jacobs, Anna M. Bowsher, Jason D. Boisvert, Roxanna M. Smolowitz, Jacob Pantazis, Kate Annunziato, Malina Nguyen, Alicia Timme-Laragy. Embryonic exposures to mono-2-ethylhexyl phthalate induce larval steatosis in zebrafish independent of Nrf2a signaling. Journal of Developmental Origins of Health and Disease 2021; 12(1) doi: 10.1017/S2040174420000057
|
| 339 |
Deepika Kumari, Jyoti Gautam, Vipin Sharma, Sonu Kumar Gupta, Soumalya Sarkar, Pradipta Jana, Vikas Singhal, Prabhakar Babele, Parul Kamboj, Sneh Bajpai, Ruchi Tandon, Yashwant Kumar, Madhu Dikshit. Effect of herbal extracts and Saroglitazar on high-fat diet-induced obesity, insulin resistance, dyslipidemia, and hepatic lipidome in C57BL/6J mice. Heliyon 2023; 9(11) doi: 10.1016/j.heliyon.2023.e22051
|
| 340 |
Charis Liapi. The interaction of choline and one-carbon / folate metabolism derangements on the cardiac remodeling process with or without diabetes. Review of Clinical Pharmacology and Pharmacokinetics - International Edition 2024; 38(Sup2) doi: 10.61873/OVUE2319
|
| 341 |
P. Melendez, M. Whitney, F. Williams, P. Pinedo, D. Manriquez, S.G. Moore, M.C. Lucy, P. Pithua, S.E. Poock. Technical note: Evaluation of fine needle aspiration cytology for the diagnosis of fatty liver in dairy cattle. Journal of Dairy Science 2018; 101(5) doi: 10.3168/jds.2017-13346
|
| 342 |
Nicholas D. Johnson, Xiumei Wu, Christopher D. Still, Xin Chu, Anthony T. Petrick, Glenn S. Gerhard, Karen N. Conneely, Johanna K. DiStefano. Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD. Clinical Epigenetics 2021; 13(1) doi: 10.1186/s13148-021-01129-y
|
| 343 |
Jin Wook Choi, Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim. Bioelectrical Impedance Analysis Can Be an Effective Tool for Screening Fatty Liver in Patients with Suspected Liver Disease. Healthcare 2022; 10(11) doi: 10.3390/healthcare10112268
|
| 344 |
Fatemeh Izadi, Amirhosein Farrokhzad, Babak Tamizifar, Mohammad Javad Tarrahi, Mohammad Hassan Entezari. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non‐alcoholic fatty liver disease: A double‐blind randomized controlled clinical trial. Phytotherapy Research 2021; 35(1) doi: 10.1002/ptr.6826
|
| 345 |
Sahar Yarahmadi, Mohammadjavad Sotoudeheian, Navid Farahmandian, Yaser Mohammadi, Mehdi Koushki, Esmaeel Babaeenezhad, Zeynab Yousefi, Soudabeh Fallah. Effect of resveratrol on key signaling pathways including SIRT1/AMPK/Smad3/TGF-β and miRNA-141 related to NAFLD in an animal model. Research in Pharmaceutical Sciences 2025; 20(3) doi: 10.4103/RPS.RPS_220_24
|
| 346 |
E. Cipponeri, N. Vitturi, V. Mariano, F. Boscari, S. Galasso, C. Crepaldi, G. P. Fadini, S. Vigili de Kreutzenberg, M. C. Marescotti, E. Iori, F. Cavallin, L. Sartori, A. Baritussio, A. Avogaro, D. Bruttomesso. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. Journal of Endocrinological Investigation 2019; 42(9) doi: 10.1007/s40618-019-01031-8
|
| 347 |
Carlo Ratti, Mattia Malaguti, D'Aniello Emanuele, Antonio Bellasi, Gianluca Sanna. Understanding MASLD — from molecular pathogenesis to cardiovascular risk: A concise review for the clinical cardiologist. Atherosclerosis 2025; 409 doi: 10.1016/j.atherosclerosis.2025.120495
|
| 348 |
Jinping Lai, Hanlin L. Wang, Xuchen Zhang, Huamin Wang, Xiuli Liu. Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease. Archives of Pathology & Laboratory Medicine 2022; 146(8) doi: 10.5858/arpa.2021-0339-RA
|
| 349 |
Yanli Jiang, Jie Zou, Fengxian Fan, Pin Yang, Laiyang Ma, Tiejun Gan, Shaoyu Wang, Jing Zhang. Application of multi-echo Dixon and MRS in quantifying hepatic fat content and staging liver fibrosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-39361-6
|
| 350 |
Chuang Li, Weiwei Kong, Lixia Kang, Tiehan Zhang, Weiqun Zhang, Weidong Wang. Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease. Journal of Medical Biochemistry 2021; 40(1) doi: 10.5937/jomb0-24666
|
| 351 |
Ghulam Fatima, Kaneez Zainab Rabail, Mona Humaira, Afsana Khaskheli, Benazir Bughio, Kashaf Nida. Frequency of Liver Fibrosis by Non Invasive Marker in Patients with Non-Alcohol Fatty Liver Diseases. Pakistan Journal of Health Sciences 2023; doi: 10.54393/pjhs.v4i02.572
|
| 352 |
Eyun Song, Jung A. Kim, Eun Roh, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi. Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.647459
|
| 353 |
John C. Parker, Andreas G. Moraitis, Joseph K. Belanoff. Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism. AACE Clinical Case Reports 2022; 8(1) doi: 10.1016/j.aace.2021.07.001
|
| 354 |
Xiaoyan Qi, Jinping Lai. Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH). International Journal of Molecular Sciences 2022; 23(21) doi: 10.3390/ijms232113501
|
| 355 |
Babita Shashni, Yuya Tajika, Yutaka Ikeda, Yuji Nishikawa, Yukio Nagasaki. Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis. Biomaterials 2023; 295 doi: 10.1016/j.biomaterials.2023.122047
|
| 356 |
Bingqian Wang, Wenna Li, Hezhi Fang, Huaibin Zhou. Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9619
|
| 357 |
Jingjing Jiao, Xuchen Zhang. Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights. Advances in Anatomic Pathology 2025; 32(6) doi: 10.1097/PAP.0000000000000483
|
| 358 |
Debojyoti Halder, Ashutosh Gupta, Subhasis Chakraborty, Partha Roy, Kalyan Kumar Sen. Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma. Nano-Structures & Nano-Objects 2024; 40 doi: 10.1016/j.nanoso.2024.101342
|
| 359 |
Giacinto Libertini, Graziamaria Corbi, Valeria Conti, Olga Shubernetskaya, Nicola Ferrara. Evolutionary Gerontology and Geriatrics. Advances in Studies of Aging and Health 2021; 2 doi: 10.1007/978-3-030-73774-0_7
|
| 360 |
Maryam Issa Al-Ani, Huda Hameed Salman, Shaymaa Khalid Abdulqader, Nabeeha Najatee Akram, Ghasaq Ma'an Bakr Bakr . Association Between Non-Alcoholic Fatty Liver Disease and Subclinical Atherosclerosis: A Study of Carotid Intima-Media Thickness . Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 2025; 9(2) doi: 10.54133/ajms.v9i2.2391
|
| 361 |
Beyza Bulutoglu, Camilo Rey-Bedón, Young Bok (Abraham) Kang, Safak Mert, Martin L. Yarmush, O. Berk Usta. A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation. Lab on a Chip 2019; 19(18) doi: 10.1039/C9LC00354A
|
| 362 |
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver Disease. Advanced Biosystems 2019; 3(8) doi: 10.1002/adbi.201900104
|
| 363 |
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare Patients. American Journal of Gastroenterology 2020; 115(4) doi: 10.14309/ajg.0000000000000484
|
| 364 |
Yuling Xing, Yunfeng Zhen, Liqun Yang, Lijing Huo, Huijuan Ma. Association between hemoglobin glycation index and non-alcoholic fatty liver disease. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1094101
|
| 365 |
Marzieh Belji Kangarlou, Ali Khavanin, Farshad Nadri, Zahra Goodarzi, Esmaeil Karami, Ali Rashidy-Pour, Mehrafarin Kiani, Raheleh Hashemi Habybabady. Noise and silver nanoparticles induce hepatotoxicity via CYP450/NF-Kappa B 2 and p53 signaling pathways in a rat model. Toxicology and Industrial Health 2024; 40(4) doi: 10.1177/07482337241233317
|
| 366 |
Enxiang Zhang, Shutao Yin, Chong Zhao, Lihong Fan, Hongbo Hu. Involvement of activation of PLIN5-Sirt1 axis in protective effect of glycycoumarin on hepatic lipotoxicity. Biochemical and Biophysical Research Communications 2020; 528(1) doi: 10.1016/j.bbrc.2020.05.072
|
| 367 |
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?. Abdominal Radiology 2020; 45(11) doi: 10.1007/s00261-020-02783-1
|
| 368 |
Paola Secchiero, Erika Rimondi, Annalisa Marcuzzi, Giovanna Longo, Chiara Papi, Marta Manfredini, Matteo Fields, Lorenzo Caruso, Roberta Di Caprio, Anna Balato. Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota. International Journal of Molecular Sciences 2024; 25(15) doi: 10.3390/ijms25158098
|
| 369 |
Tamara Nazar Saeed, Ali Fawzi Al-Hussainy, Gaurav Sanghvi, R. Roopashree, Aditya Kashyap, D. Alex Anand, Rajashree Panigrahi, Zafar Aminov, Sada Ghalib Taher, Mariem Alwan, Mahmood Jawad, Hiba Mushtaq. Effects of alpha-lipoic acid in non-alcoholic fatty liver disease (NAFLD): a systematic review of literature. Journal of Diabetes & Metabolic Disorders 2026; 25(2) doi: 10.1007/s40200-026-01979-4
|
| 370 |
Emma Henriksson, Birgitte Andersen. FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.601349
|
| 371 |
|
| 372 |
Arunaksharan Narayanankutty. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases. Current Drug Targets 2019; 20(10) doi: 10.2174/1389450120666190222181506
|
| 373 |
Giuseppe Derosa, Angela D’Angelo, Pamela Maffioli, Laura Cucinella, Rossella Elena Nappi. The Use of Nigella sativa in Cardiometabolic Diseases. Biomedicines 2024; 12(2) doi: 10.3390/biomedicines12020405
|
| 374 |
Veronica A. Mullins, William Bresette, Laurel Johnstone, Brian Hallmark, Floyd H. Chilton. Genomics in Personalized Nutrition: Can You “Eat for Your Genes”?. Nutrients 2020; 12(10) doi: 10.3390/nu12103118
|
| 375 |
Paul F. Lebeau, Jae Hyun Byun, Khrystyna Platko, Melissa E. MacDonald, Samantha V. Poon, Mahi Faiyaz, Nabil G. Seidah, Richard C. Austin. Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in mice. Journal of Biological Chemistry 2019; 294(23) doi: 10.1074/jbc.RA119.008094
|
| 376 |
Tahmine Tavakoli, Asghar Zarban, Reyhaneh Hooshyar, Fatemeh Salmani, Hamidreza Tajik. Improvement of thiol groups and total antioxidant capacity in patients with non-alcoholic fatty liver after treatment with pioglitazone. Archives of Physiology and Biochemistry 2022; 128(6) doi: 10.1080/13813455.2020.1784953
|
| 377 |
Rodica Talmaci. miRNA – molecular biomarkers in non-alcoholic fatty liver disease: potential targets in nutritional interventions. Dietetician.ro 2023; 3(3) doi: 10.26416/Diet.3.3.2023.8754
|
| 378 |
Zahra Koohestani Sini, Mohammad Esmaeil Afzalpour, Mohsen Mohammadnia Ahmadi, Mohammad Ali Sardar, Sattar Gorgani Firuzjaee. The Effect of Aerobic Continuous Training on Myonectin, Insulin Resistance and Liver Enzymes in Rats with Nonalcoholic Fatty Liver Disease. Annals of Applied Sport Science 2020; 8(4) doi: 10.29252/aassjournal.855
|
| 379 |
Jelena Mustra Rakic, Chun Liu, Sudipta Veeramachaneni, Dayong Wu, Ligi Paul, Lynne M. Ausman, Xiang-Dong Wang. Dietary lycopene attenuates cigarette smoke-promoted nonalcoholic steatohepatitis by preventing suppression of antioxidant enzymes in ferrets. The Journal of Nutritional Biochemistry 2021; 91 doi: 10.1016/j.jnutbio.2021.108596
|
| 380 |
Haofei Hu, Yong Han, Yufei Liu, Mijie Guan, Qijun Wan. Triglyceride: A mediator of the association between waist-to-height ratio and non-alcoholic fatty liver disease: A second analysis of a population-based study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.973823
|
| 381 |
Vinay Narladkar, Aman Agrawal, Sanket S Bakshi, Swarupa Chakole, Aniket G Pathade, Seema Yelne. Unravelling the Interplay: Exploring the Influence of Previous Hepatitis B Virus, Hepatitis A Virus, and Hepatitis E Virus Infections on Non-alcoholic Fatty Liver Disease. Cureus 2023; doi: 10.7759/cureus.44969
|
| 382 |
Yuanyuan Zhang, Juyi Li, Huaizhen Liu. Correlation between the thyroid hormone levels and nonalcoholic fatty liver disease in type 2 diabetic patients with normal thyroid function. BMC Endocrine Disorders 2022; 22(1) doi: 10.1186/s12902-022-01050-2
|
| 383 |
Mayumi Nagashimada, Masao Honda. Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics. International Journal of Molecular Sciences 2021; 22(15) doi: 10.3390/ijms22158008
|
| 384 |
Sadia Ashraf, Nadia Ashraf, Gizem Yilmaz, Romain Harmancey. Crosstalk between beta‐adrenergic and insulin signaling mediates mechanistic target of rapamycin hyperactivation in liver of high‐fat diet‐fed male mice. Physiological Reports 2021; 9(13) doi: 10.14814/phy2.14958
|
| 385 |
Monika Kubacka, Barbara Nowak, Monika Zadrożna, Małgorzata Szafarz, Gniewomir Latacz, Henryk Marona, Jacek Sapa, Szczepan Mogilski, Marek Bednarski, Magdalena Kotańska. Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome. Metabolites 2023; 13(11) doi: 10.3390/metabo13111130
|
| 386 |
Assim A. Alfadda, Suphia M. Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Nasser M. Aldaghri, Simon D. Taylor-Robinson, Saleh A. Alqahtani, Rukhsana Gul, Abdulrahman M. Almaghamsi. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes. Saudi Journal of Gastroenterology 2022; 28(6) doi: 10.4103/sjg.sjg_73_22
|
| 387 |
Clarissa Elysia Fu, Cheng Han Ng, Jie Ning Yong, Kai En Chan, Jieling Xiao, Benjamin Nah, Shirley Huey Shin Bong, Khin Maung Win, Aung Hlaing Bwa, Wen Hui Lim, Darren Jun Hao Tan, Rebecca Wenling Zeng, Nicholas Chew, Margaret L.P. Teng, Mohammad Shadab Siddiqui, Jude A. Oben, Arun J. Sanyal, Vincent Wai-Sun Wong, Mazen Noureddin, Mark Muthiah. A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease. Endocrine Practice 2023; 29(1) doi: 10.1016/j.eprac.2022.10.007
|
| 388 |
David Mantle, Iain P Hargreaves. Coenzyme Q10 supplementation in non-alcoholic fatty liver disease: an overview. Gastrointestinal Nursing 2020; 18(2) doi: 10.12968/gasn.2020.18.2.22
|
| 389 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver disease. Revista de Gastroenterología de México (English Edition) 2019; 84(1) doi: 10.1016/j.rgmxen.2019.02.003
|
| 390 |
Saimila Momin, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; doi: 10.1007/978-981-15-5471-1_15
|
| 391 |
Sebastian Holländer, Maximilian von Heesen, Gereon Gäbelein, Julie Mercier, Matthias W. Laschke, Michael D. Menger, Matthias Glanemann, Antonios E. Spiliotis. Perioperative treatment with cilostazol reverses steatosis and improves liver regeneration after major hepatectomy in a steatotic rat model. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-87135-z
|
| 392 |
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver Tissues. Applied In Vitro Toxicology 2018; 4(3) doi: 10.1089/aivt.2018.0015
|
| 393 |
Yayun Lu, Qing Xia, Liangyu Wu, Zhiping Xie. Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1026054
|
| 394 |
İsa Çam, Ural Koc, Samet Genez, Abdullah Güneş. Computed Tomography Measurements of Hepatic Steatosis in Cholelitihiasis and Cholecystectomy Cases Using Unenhanced Images. Journal of Medical Imaging and Radiation Sciences 2020; 51(1) doi: 10.1016/j.jmir.2019.12.003
|
| 395 |
Erenius Toppo, Naif Abdullah Al-Dhabi, Chinnakulandai Sankar, Sanmugapriya Nagul Kumar, Kanniappan Buvanesvaragurunathan, Santhanam Sylvester Darvin, Antony Stalin, Kedeke Balakrishna, Stanislaus Antony Ceasar, Perumal Pandikumar, Savarimuthu Ignacimuthu, Kuppusamy Sivasankaran, Paul Agastian. Hepatoprotective effect of selected isoandrographolide derivatives on steatotic HepG2 cells and High Fat Diet fed rats. European Journal of Pharmacology 2021; 899 doi: 10.1016/j.ejphar.2021.174056
|
| 396 |
Charlotte D’Mello, Mark G. Swain. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes. 2021; doi: 10.1016/B978-0-12-821927-0.00007-3
|
| 397 |
Gary A. Abrams, Deanna Ware, Margaret M. Byrne, Eric M. Hecht. Risk stratification of adolescents for the screening of non‐alcoholic fatty liver disease. Pediatric Obesity 2022; 17(9) doi: 10.1111/ijpo.12924
|
| 398 |
Faisal M Sanai, Faisal Abaalkhail, Fuad Hasan, Muhammad Hamed Farooqi, Nawal Al Nahdi, Zobair M Younossi. Management of nonalcoholic fatty liver disease in the Middle East. World Journal of Gastroenterology 2020; 26(25): 3528-3541 doi: 10.3748/wjg.v26.i25.3528
|
| 399 |
Ângela Fernandes, Ana M. Dias, Mariana C. Silva, Joana Gaifem, Catarina M. Azevedo, Iago Carballo, Salomé S. Pinho. Comprehensive Glycoscience. 2021; doi: 10.1016/B978-0-12-819475-1.00036-5
|
| 400 |
Xiaoyan Hao, Cong Ma, Tianyuan Xiang, Lei Ou, Qiang Zeng. Associations Among Methylene Tetrahydrofolate Reductase rs1801133 C677T Gene Variant, Food Groups, and Non-alcoholic Fatty Liver Disease Risk in the Chinese Population. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.568398
|
| 401 |
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation. Nutrients 2019; 11(4) doi: 10.3390/nu11040872
|
| 402 |
Michele Bernardini, Mariachiara di Cosmo, Gaia Barone, Luca Romeo, Emanuele Frontoni. Machine Learning-Based Clinical Decision Support System for Hepatic Fibrosis Risk Prediction in General Practice. ACM Transactions on Computing for Healthcare 2026; 7(2) doi: 10.1145/3788673
|
| 403 |
Ali Kermanizadeh, Jessica Valli, Katarzyna Sanchez, Simon Hutter, Agnieszka Pawlowska, Graeme Whyte, Wolfgang Moritz, Vicki Stone. Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASH. Archives of Toxicology 2022; 96(1) doi: 10.1007/s00204-021-03181-2
|
| 404 |
Jolie Boullion, Amanda Husein, Akshat Agrawal, Diensn Xing, Md Ismail Hossain, Md Shenuarin Bhuiyan, Oren Rom, Steven A Conrad, John A Vanchiere, A Wayne Orr, Christopher G Kevil, Mohammad Alfrad Nobel Bhuiyan. Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease. The Journal of Clinical Endocrinology & Metabolism 2025; 110(11) doi: 10.1210/clinem/dgaf111
|
| 405 |
Chase W. Kessinger, Lin Chen, Felicia Huang, Jierui Lin, Amanda Davenport, Zhiqiang Lin, Rami Salim Najjar. Diet-induced steatohepatitis does not cause heart failure with preserved ejection fraction in male middle-aged C57BL/6N mice. PLOS One 2025; 20(12) doi: 10.1371/journal.pone.0339642
|
| 406 |
|
| 407 |
Abid Suddle, Helen Reeves, Richard Hubner, Aileen Marshall, Ian Rowe, Dina Tiniakos, Stefan Hubscher, Mark Callaway, Dinesh Sharma, Teik Choon See, Maria Hawkins, Suzanne Ford-Dunn, Sarah Selemani, Tim Meyer. British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults. Gut 2024; 73(8) doi: 10.1136/gutjnl-2023-331695
|
| 408 |
Zou-Han Lin, Pin-I Chou, Jia-Wei Chang, Zong-Chen Lin, Yuan-Ting Sun, Ming-Hui Chang, Shih-En Huang, Yu-Min Yeh, Chien-Chin Chen, I-Chen Peng. Promoter demethylation and protein O-GlcNAcylation-mediated enhancement of fatty acid synthase contributes to hepatic steatosis and inflammation in MASLD. The Journal of Nutritional Biochemistry 2026; 150 doi: 10.1016/j.jnutbio.2025.110227
|
| 409 |
Ewa Garbiec, Judyta Cielecka-Piontek, Magdalena Kowalówka, Magdalena Hołubiec, Przemysław Zalewski. Genistein—Opportunities Related to an Interesting Molecule of Natural Origin. Molecules 2022; 27(3) doi: 10.3390/molecules27030815
|
| 410 |
Abid Rasool, Ajaz Qadir, Tajali Sahar, Mushtaq Ahmed Khan. Correlation of Cytokeratin-18 as a Marker of Cardiovascular Risk Assessment in Nonalcoholic Fatty Liver Disease in Nonobese and Nondiabetic Patients. Asian Journal of Pharmaceutical Research and Health Care 2022; 14(3) doi: 10.4103/ajprhc.ajprhc_42_22
|
| 411 |
Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov. Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes. Diabetes mellitus 2018; 20(6) doi: 10.14341/DM9374
|
| 412 |
Xiaozhong Huang, Fan Lee, Yao Teng, Corey Bryen Lingam, Zijian Chen, Min Sun, Ziwei Song, Gowri M. Balachander, Hwa Liang Leo, Qiongyu Guo, Imran Shah, Hanry Yu. Sequential drug delivery for liver diseases. Advanced Drug Delivery Reviews 2019; doi: 10.1016/j.addr.2019.11.001
|
| 413 |
Mohamed Mostafa, Amrou Abdelkader, John J. Evans, Catherine E. Hagen, Christopher P. Hartley. Fatty Liver Disease: A Practical Approach. Archives of Pathology & Laboratory Medicine 2020; 144(1) doi: 10.5858/arpa.2019-0341-RA
|
| 414 |
Emma Wilkinson, Yan-Hong Cui, Yu-Ying He. Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases. International Journal of Molecular Sciences 2021; 22(4) doi: 10.3390/ijms22041949
|
| 415 |
Yanyan Xuan, Dingting Wu, Yuhong Jin, Xuxia Yu, Jingbo Yu, Yinwei Zhang. Utility of the serum alanine aminotransferase to high density lipoprotein cholesterol ratio in evaluating nonalcoholic fatty liver disease and liver fibrosis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-06171-x
|
| 416 |
Avishek Mandal. Cattle Diseases - Molecular and Biochemical Approach. Veterinary Medicine and Science 2023; 16 doi: 10.5772/intechopen.108151
|
| 417 |
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólico. Revista de Gastroenterología de México 2019; 84(1) doi: 10.1016/j.rgmx.2018.11.007
|
| 418 |
Ju Wu, Wenjing Yu, Linglong Huang, Shuangshuang Hou, Yanan Huang, Zhihua Huang, Zhiyuan Dai, Jiajun Yin, Zhequn Nie. The HbA1c/HDL-C ratio as a screening indicator of NAFLD in U.S. adults: a cross-sectional NHANES analysis (2017–2020). BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03974-0
|
| 419 |
Elizabeth J. Millings, Maria Caterina De Rosa, Sarah Fleet, Kazuhisa Watanabe, Richard Rausch, Dieter Egli, Gen Li, Charles A. Leduc, Yiying Zhang, Stuart G. Fischer, Rudolph L. Leibel, Leonidas G. Koniaris. ILDR2 has a negligible role in hepatic steatosis. PLOS ONE 2018; 13(5) doi: 10.1371/journal.pone.0197548
|
| 420 |
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?. Nutrients 2019; 11(12) doi: 10.3390/nu11122878
|
| 421 |
Eline H. van den Berg, Eke G. Gruppen, Sanam Ebtehaj, Stephan J.L. Bakker, Uwe J.F. Tietge, Robin P.F. Dullaart. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease. Atherosclerosis 2018; 277 doi: 10.1016/j.atherosclerosis.2018.07.028
|
| 422 |
Francesca Oppedisano, Carolina Muscoli, Vincenzo Musolino, Cristina Carresi, Roberta Macrì, Caterina Giancotta, Francesca Bosco, Jessica Maiuolo, Federica Scarano, Sara Paone, Saverio Nucera, Maria Caterina Zito, Miriam Scicchitano, Stefano Ruga, Monica Ragusa, Ernesto Palma, Annamaria Tavernese, Rocco Mollace, Ezio Bombardelli, Vincenzo Mollace. The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter Subfamily. Nutrients 2020; 12(5) doi: 10.3390/nu12051435
|
| 423 |
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic review. Obesity Reviews 2019; 20(7) doi: 10.1111/obr.12853
|
| 424 |
Shu Liang, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang, Kamal D. Moudgil. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut Microbiota. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/5378961
|
| 425 |
Jing Zhang, Mengxuan Shi, Chunna Zhao, Guangcai Liang, Chuan Li, Xiaomeng Ge, Caixia Pei, Yawei Kong, Dongdan Li, Wenli Yang, Bingyan Cao, Libing Fu, Yinkun Yan, Jie Wu, Jin Zhou, Yongli Fang, Xi Meng, Yong Li, Liming Wang, Wei-Hua Chen, Wei-Kai Wu. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children. Microbiology Spectrum 2024; 12(2) doi: 10.1128/spectrum.01006-23
|
| 426 |
Ernesto Cortes, Dariusz Lachowski, Alistair Rice, Antonios Chronopoulos, Benjamin Robinson, Stephen Thorpe, David A Lee, Lucia A Possamai, Haiyun Wang, David J Pinato, Armando E. del Río Hernández. Retinoic Acid Receptor‐β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin‐Driven Activation and Durotaxis in Hepatic Stellate Cells. Hepatology 2019; 69(2) doi: 10.1002/hep.30193
|
| 427 |
Samira Kazemi, Farzad Shidfar, Simin Ehsani, Peyman Adibi, Leila Janani, Omid Eslami. The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: A randomized controlled trial. Complementary Therapies in Clinical Practice 2020; 41 doi: 10.1016/j.ctcp.2020.101259
|
| 428 |
Ping Lin, Xi Yan, Siyu Jing, Yanhong Wu, Yiran Shan, Wenbo Guo, Jin Gu, Yu Li, Haibing Zhang, Hong Li. Single-cell and spatially resolved transcriptomics for liver biology. Hepatology 2024; 80(3) doi: 10.1097/HEP.0000000000000387
|
| 429 |
Yoosoo Chang, Jin-Won Noh, Joo Young Cheon, Yejin Kim, Young Dae Kwon, Seungho Ryu. Self-rated health and risk of incident non-alcoholic fatty liver disease: A cohort study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60823-8
|
| 430 |
Georgios Kalopitas, Konstantinos Arvanitakis, Olga Tsachouridou, Konstantinos Malandris, Theocharis Koufakis, Symeon Metallidis, Georgios Germanidis. Metabolic Dysfunction-Associated Steatotic Liver Disease in People Living with HIV—Limitations on Antiretroviral Therapy Selection. Life 2024; 14(6) doi: 10.3390/life14060742
|
| 431 |
Pian Xiong, Yong-Fen Zhu. Soy diet for nonalcoholic fatty liver disease. Medicine 2021; 100(22) doi: 10.1097/MD.0000000000025817
|
| 432 |
Kang Wang, Guilherme Moura Cunha, Kyle Hasenstab, Walter C. Henderson, Michael S. Middleton, Shelley A. Cole, Jason G. Umans, Tauqeer Ali, Albert Hsiao, Claude B. Sirlin. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data. American Journal of Roentgenology 2023; 221(5) doi: 10.2214/AJR.23.29607
|
| 433 |
Tasur Kumar Seen, Muntazir Sayed, Muhammad Bilal, Jonathan Vincent Reyes, Priyanka Bhandari, Vennis Lourdusamy, Ahmed Al-khazraji, Umer Syed, Yasar Sattar, Raghav Bansal. Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis. World Journal of Gastroenterology 2021; 27(23): 3238-3248 doi: 10.3748/wjg.v27.i23.3238
|
| 434 |
Giovanni Martemucci, Giuseppe Fracchiolla, Marilena Muraglia, Roberta Tardugno, Roberta Savina Dibenedetto, Angela Gabriella D’Alessandro. Metabolic Syndrome: A Narrative Review from the Oxidative Stress to the Management of Related Diseases. Antioxidants 2023; 12(12) doi: 10.3390/antiox12122091
|
| 435 |
Damien Viglino, Anais Plazanet, Sebastien Bailly, Meriem Benmerad, Ingrid Jullian-Desayes, Renaud Tamisier, Vincent Leroy, Jean-Pierre Zarski, Maxime Maignan, Marie Joyeux-Faure, Jean-Louis Pépin. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34988-2
|
| 436 |
Seon-Heui Cha, Yongha Hwang, Soo-Jin Heo, Hee-Sook Jun. Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation. Marine Drugs 2019; 17(9) doi: 10.3390/md17090486
|
| 437 |
Ioannis Katsaros, Maria Sotiropoulou, Michail Vailas, Emmanouil Ioannis Kapetanakis, Georgia Valsami, Alexandra Tsaroucha, Dimitrios Schizas. Quercetin’s Potential in MASLD: Investigating the Role of Autophagy and Key Molecular Pathways in Liver Steatosis and Inflammation. Nutrients 2024; 16(22) doi: 10.3390/nu16223789
|
| 438 |
Weon Jang, Ji Soo Song. Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review. Diagnostics 2023; 13(11) doi: 10.3390/diagnostics13111852
|
| 439 |
MicroRNA-122 regulates inflammatory and autophagic proteins by downregulating pyruvate kinase M2 in non-alcoholic fatty liver disease. Molecular and Cellular Biochemistry 2025; 480(5) doi: 10.1007/s11010-024-05174-y
|
| 440 |
Arya M. Sharma. Differential indications for weight loss. Current Opinion in Endocrine and Metabolic Research 2019; 4 doi: 10.1016/j.coemr.2018.09.001
|
| 441 |
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats. Antioxidants 2019; 8(8) doi: 10.3390/antiox8080276
|
| 442 |
Dragana Rajcic, Anja Baumann, Angélica Hernández-Arriaga, Annette Brandt, Anika Nier, Cheng Jun Jin, Victor Sánchez, Finn Jung, Amélia Camarinha-Silva, Ina Bergheim. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase. Redox Biology 2021; 41 doi: 10.1016/j.redox.2021.101879
|
| 443 |
Shaza Asif, Ri Youn Kim, Thet Fatica, Jordan Sim, Xiaoling Zhao, Yena Oh, Alix Denoncourt, Angela C. Cheung, Michael Downey, Erin E. Mulvihill, Kyoung-Han Kim. Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis. Molecular Metabolism 2022; 61 doi: 10.1016/j.molmet.2022.101494
|
| 444 |
Qihao Zhang, Xianfu Luo, Liangdong Zhou, Thanh D. Nguyen, Martin R. Prince, Pascal Spincemaille, Yi Wang. Fluid Mechanics Approach to Perfusion Quantification: Vasculature Computational Fluid Dynamics Simulation, Quantitative Transport Mapping (QTM) Analysis of Dynamics Contrast Enhanced MRI, and Application in Nonalcoholic Fatty Liver Disease Classification. IEEE Transactions on Biomedical Engineering 2023; 70(3) doi: 10.1109/TBME.2022.3207057
|
| 445 |
Tiziana Ciarambino, Pietro Crispino, Gloria Guarisco, Mauro Giordano. Gender Differences in Insulin Resistance: New Knowledge and Perspectives. Current Issues in Molecular Biology 2023; 45(10) doi: 10.3390/cimb45100496
|
| 446 |
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón. Silymarin is an ally against insulin resistance: A review. Annals of Hepatology 2021; 23 doi: 10.1016/j.aohep.2020.08.072
|
| 447 |
Valerio Azzimato, Ping Chen, Emelie Barreby, Cecilia Morgantini, Laura Levi, Ana Vankova, Jennifer Jager, André Sulen, Marina Diotallevi, Joanne X. Shen, Anne Miller, Ewa Ellis, Mikael Rydén, Erik Näslund, Anders Thorell, Volker M. Lauschke, Keith M. Channon, Mark J. Crabtree, Arvand Haschemi, Siobhan M. Craige, Mattia Mori, Francesco Spallotta, Myriam Aouadi. Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity. Gastroenterology 2021; 161(6) doi: 10.1053/j.gastro.2021.08.030
|
| 448 |
Daiane Costa dos Santos, Josemar Gonçalves de Oliveira Filho, Tainara Leal de Sousa, Carolina Barbosa Ribeiro, Mariana Buranelo Egea. Ameliorating effects of metabolic syndrome with the consumption of rich-bioactive compounds fruits from Brazilian Cerrado: a narrative review. Critical Reviews in Food Science and Nutrition 2022; 62(27) doi: 10.1080/10408398.2021.1916430
|
| 449 |
D.H. Seo, Y.-h. Lee, S.W. Park, Y.J. Choi, B.W. Huh, E. Lee, K.B. Huh, S.H. Kim, B.-S. Cha. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. Diabetes & Metabolism 2020; 46(5) doi: 10.1016/j.diabet.2019.10.004
|
| 450 |
Alessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, Francesco Massimo Perla, Fabrizio Ceci, Antonio Angeloni, Laura D’Erasmo, Michele Di Martino, Marcello Arca. Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity. Pediatric Research 2019; 85(5) doi: 10.1038/s41390-019-0303-1
|
| 451 |
Luis Cano, Juan Pablo Cerapio, Eloy Ruiz, Agnès Marchio, Bruno Turlin, Sandro Casavilca, Luis Taxa, Guillaume Marti, Eric Deharo, Pascal Pineau, Stéphane Bertani. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South America. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28286-0
|
| 452 |
Maysa Ahmed Mobasher, Hala Galal El-Tantawi, Karim Samy El-Said. Metformin Ameliorates Oxidative Stress Induced by Diabetes Mellitus and Hepatocellular Carcinoma in Rats. Reports of Biochemistry and Molecular Biology 2020; 9(1) doi: 10.29252/rbmb.9.1.115
|
| 453 |
Matteo Tardelli, Francesca V. Bruschi, Thierry Claudel, Claudia D. Fuchs, Nicole Auer, Victoria Kunczer, Tatjana Stojakovic, Hubert Scharnagl, Aida Habib, Gernot F. Grabner, Robert Zimmermann, Sophie Lotersztajn, Michael Trauner. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption. Journal of Lipid Research 2019; 60(7) doi: 10.1194/jlr.M093369
|
| 454 |
Jovana Milic, Valentina Menozzi, Filippo Schepis, Andrea Malagoli, Giulia Besutti, Iacopo Franconi, Alessandro Raimondi, Federica Carli, Cristina Mussini, Giada Sebastiani, Giovanni Guaraldi. Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV. AIDS 2020; 34(13) doi: 10.1097/QAD.0000000000002650
|
| 455 |
Jiatong Xu, Junni Shi, Yunqian Huang, Chuanjian Chen, Guanghua Xiang, Wen Zheng, Man Chen. Diagnostic value of ultrasound peritumoral viscoelasticity parameters in breast cancer: enhancing BI-RADS classification performance. BMC Medical Imaging 2026; 26(1) doi: 10.1186/s12880-025-02144-8
|
| 456 |
Jiayun Ge, Yannan Bai, Bo Tang, Dong Wei, Maolin Yan, Amir Radfar. The Gene Signature Associated with Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Journal of Oncology 2021; 2021 doi: 10.1155/2021/6630535
|
| 457 |
Pammar Aryan. Nonalcoholic fatty liver disease: a review of physiology, treatments, and market outlook. Advances in Tissue Engineering & Regenerative Medicine: Open Access 2023; 9(1) doi: 10.15406/atroa.2023.09.00140
|
| 458 |
Wenlong Hao, Minghao Li, Qingmin Cai, Shiying Wu, Xiangyao Li, Quanyu He, Yongbin Hu. Roles of NRF2 in Fibrotic Diseases: From Mechanisms to Therapeutic Approaches. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.889792
|
| 459 |
Katherine J.P. Schwenger, Yasaman Ghorbani, Kuorosh Rezaei, Sandra E. Fischer, Timothy D. Jackson, Allan Okrainec, Johane P. Allard. Relationship between dietary intake components and hepatic fibrosis in those with obesity before and 1 year after bariatric surgery. Nutrition 2023; 114 doi: 10.1016/j.nut.2023.112095
|
| 460 |
Fernanda Torres Quitete, Giulia Medeiros Almeida Santos, Leilson de Oliveira Ribeiro, Cristiane Aguiar da Costa, Suely Pereira Freitas, Virgínia Martins da Matta, Julio Beltrame Daleprane. Phenolic-rich smoothie consumption ameliorates non-alcoholic fatty liver disease in obesity mice by increasing antioxidant response. Chemico-Biological Interactions 2021; 336 doi: 10.1016/j.cbi.2021.109369
|
| 461 |
Nora A. Alfadda, Ghadeer S. Aljuraiban, Hadeel M. Awwad, Mohammad S. Khaleel, Abdulrahman M. Almaghamsi, Suphia M. Sherbeeni, Adel N. Alqutub, Abdullah S. Aldosary, Assim A. Alfadda. Higher carbohydrate intake in relation to non-alcoholic fatty liver disease in patients with type 2 diabetes. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.996004
|
| 462 |
Diego Liviu Boaru, Diego De Leon-Oliva, Patricia De Castro-Martinez, Cielo Garcia-Montero, Oscar Fraile-Martinez, Beatriz García-González, Isabel Pérez-González, Majd N. Michael Alhaddadin, Silvestra Barrena-Blázquez, Laura Lopez-Gonzalez, Basilio de la Torre, Luis G. Guijarro, Leonel Pekarek, Miguel A. Saez, Laura Ríos-Espinosa, María Jesús Garrido-Gil, Maria José Gimeno-Longas, Tatiana Pekarek, Raul Diaz-Pedrero, Melchor Alvarez-Mon, Miguel A. Ortega. Cuproptosis: Current insights into its multifaceted role in disease, cancer, and translational/therapeutic opportunities. Biomedicine & Pharmacotherapy 2025; 190 doi: 10.1016/j.biopha.2025.118422
|
| 463 |
Ju-Yeon Lee, Jin Lee, Won-Kyo Jung, Jae-Young Je, Sei-Jung Lee. Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells. Cytotechnology 2026; 78(3) doi: 10.1007/s10616-026-00967-z
|
| 464 |
Zun Mao, Zhi-xiang Gao, Tong Ji, Sheng Huan, Guo-ping Yin, Long Chen. Bidirectional two-sample mendelian randomization analysis identifies causal associations of MRI-based cortical thickness and surface area relation to NAFLD. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02043-x
|
| 465 |
Olfa Khalifa, Kamal H. Mroue, Raghvendra Mall, Ehsan Ullah, Nayla S. Al-Akl, Abdelilah Arredouani. Investigation of the Effect of Exendin-4 on Oleic Acid-Induced Steatosis in HepG2 Cells Using Fourier Transform Infrared Spectroscopy. Biomedicines 2022; 10(10) doi: 10.3390/biomedicines10102652
|
| 466 |
Luigi Aloia. Epigenetic Regulation of Cell-Fate Changes That Determine Adult Liver Regeneration After Injury. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.643055
|
| 467 |
Vasile Mihai Sularea, Jamie A Sugrue, Cliona O’Farrelly. Innate antiviral immunity and immunometabolism in hepatocytes. Current Opinion in Immunology 2023; 80 doi: 10.1016/j.coi.2022.102267
|
| 468 |
Siavash Mehdizadeh Seraj, Abdullah Al-Zaghal, Mahdi Z. Zadeh, Pegah Jahangiri, Kamyar Pournazari, William Y. Raynor, Thomas J. Werner, Poul F. Høilund-Carlsen, Abass Alavi, Stephen J. Hunt. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI. Nuclear Medicine Communications 2019; 40(5) doi: 10.1097/MNM.0000000000001000
|
| 469 |
Yuling Xing, Tiantian Cheng, Fei Zhou, Huijuan Ma. The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022; doi: 10.2147/DMSO.S348870
|
| 470 |
Shiludi Longkumer, Maitrayee Dutta Swargiary. Non-alcoholic fatty liver disease in Northeast India: a narrative review of rising metabolic syndrome. Egyptian Liver Journal 2026; 16(1) doi: 10.1186/s43066-026-00489-5
|
| 471 |
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou, Gianfranco D. Alpini. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes. PLOS ONE 2020; 15(5) doi: 10.1371/journal.pone.0232630
|
| 472 |
Julio Plaza-Díaz, Patricio Solis-Urra, Jerónimo Aragón-Vela, Fernando Rodríguez-Rodríguez, Jorge Olivares-Arancibia, Ana I. Álvarez-Mercado. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines 2021; 9(2) doi: 10.3390/biomedicines9020145
|
| 473 |
Sanaz Pourreza, Pouria Sefidmooye Azar, Sarvin Sanaie, Nooshin Noshadi, Saeedeh Jalali, Hamid Reza Niazkar, Arash karimi, Mahdi Vajdi, Talha Bin Emran. Therapeutic Effects and Mechanisms of Action of Garlic (Allium sativum) on Nonalcoholic Fatty Liver Disease: A Comprehensive Systematic Literature Review. Evidence-Based Complementary and Alternative Medicine 2022; 2022 doi: 10.1155/2022/6960211
|
| 474 |
Helen Huang, Wireko A. Awuah, Tulika Garg, Jyi Cheng Ng, Aashna Mehta, Krishna Ramamoorthy, Jacob Kalmanovich, Mohammad M. Hasan. Prospects of evolution-based artificial intelligence models in genome-wide studies to stratify genetic risk variants in nonalcoholic fatty liver disease. Annals of Medicine & Surgery 2023; 85(6) doi: 10.1097/MS9.0000000000000743
|
| 475 |
Priyankar Dey, Richard S. Bruno. Dietary Supplements with Antioxidant Activity. 2023; doi: 10.1039/BK9781839166112-00080
|
| 476 |
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐up. Hepatology 2020; 72(2) doi: 10.1002/hep.31040
|
| 477 |
Shima Parsa, Maryam Dousti, Nasim Mohammadi, Mozhgan Abedanzadeh, Niloofar Dehdari Ebrahimi, Mahintaj Dara, Mahsa Sani, Muhammad Nekouee, Samira Sadat Abolmaali, Farnaz Sani, Negar Azarpira. The effects of simvastatin‐loaded nanoliposomes on human multilineage liver fibrosis microtissue. Journal of Cellular and Molecular Medicine 2024; 28(13) doi: 10.1111/jcmm.18529
|
| 478 |
Ning Zhang, Yuli Wang, Junli Zhang, Beibei Liu, Guixin Li, Shengliang Xin, Keshu Xu. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10316
|
| 479 |
Dieter Furthner, Daniel Weghuber, Christopher Dalus, Andreas Lukas, Hannah N. Stundner-Ladenhauf, Harald Mangge, Thomas Pixner. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps. Hormone Research in Paediatrics 2022; 95(2) doi: 10.1159/000518595
|
| 480 |
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J Lamb, Albert de Roos, Frits R Rosendaal, Renée de Mutsert. Sweet Snacks Are Positively and Fruits and Vegetables Are Negatively Associated with Visceral or Liver Fat Content in Middle-Aged Men and Women. The Journal of Nutrition 2019; 149(2) doi: 10.1093/jn/nxy260
|
| 481 |
Musaab Ahmed, Mohamed H. Ahmed. Ramadan Fasting in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Transplant, and Bariatric Surgery: A Narrative Review. Journal of Clinical Medicine 2024; 13(13) doi: 10.3390/jcm13133893
|
| 482 |
Ji-Won Jung, Feng Wang, Ayman Turk, Jeong-Su Park, Hwan Ma, Yuanqiang Ma, Hye-Rin Noh, Guoyan Sui, Dong-Su Shin, Mi-Kyeong Lee, Yoon Seok Roh. Zaluzanin C Alleviates Inflammation and Lipid Accumulation in Kupffer Cells and Hepatocytes by Regulating Mitochondrial ROS. Molecules 2023; 28(22) doi: 10.3390/molecules28227484
|
| 483 |
Vanisha Patel, Parth Shah, Daniel R. Ludwig, Chet W. Hammill, Motaz Ashkar. Development of de novo nonalcoholic fatty liver disease following pancreatectomy. Medicine 2023; 102(4) doi: 10.1097/MD.0000000000032782
|
| 484 |
Tanvi Sharma, Naveen Kaushal, Roobee Garla. Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression. World Journal of Hepatology 2025; 17(8): 108772 doi: 10.4254/wjh.v17.i8.108772
|
| 485 |
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. Bioactive Molecules in Food. Reference Series in Phytochemistry 2019; doi: 10.1007/978-3-319-78030-6_57
|
| 486 |
Ping Ye, Jijun Liu, Wuping Xu, Denghai Liu, Xiangchao Ding, Sheng Le, Hao Zhang, Shanshan Chen, Manhua Chen, Jiahong Xia. Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 Suppression. Hepatology 2019; 69(5) doi: 10.1002/hep.30485
|
| 487 |
Siân P Cartland, Nicole Tamer, Manisha S Patil, Belinda A Di Bartolo, Mary M Kavurma. A “Western Diet” promotes symptoms of hepatic steatosis in spontaneously hypertensive rats. International Journal of Experimental Pathology 2020; 101(5) doi: 10.1111/iep.12369
|
| 488 |
Navya Malladi, Aditi D. Hase, Sudheer Arava, Rajni Yadav, Jagdish Kumar Balani, Anurag Borthakur, Sanjay K. Banerjee. Empagliflozin attenuates liver steatosis and improves cardiac complications in choline-deficient high-fat diet-induced MAFLD rats. European Journal of Pharmacology 2025; 1005 doi: 10.1016/j.ejphar.2025.178067
|
| 489 |
Scott B. Reeder, Jitka Starekova. MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation. Radiology 2023; 309(1) doi: 10.1148/radiol.232552
|
| 490 |
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
|
| 491 |
Süleyman Coşgun, Derya Ünal, Aysun Çalışkan Kartal, Osman Bedir. Does Breast Feeding Protect Mothers From Obesity?. Cureus 2024; doi: 10.7759/cureus.70217
|
| 492 |
Tianhao Zhou, Debjyoti Kundu, Jonathan Robles-Linares, Vik Meadows, Keisaku Sato, Leonardo Baiocchi, Burcin Ekser, Shannon Glaser, Gianfranco Alpini, Heather Francis, Lindsey Kennedy. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. Cells 2021; 10(8) doi: 10.3390/cells10082072
|
| 493 |
Luca Lusnig, Asel Sagingalieva, Mikhail Surmach, Tatjana Protasevich, Ovidiu Michiu, Joseph McLoughlin, Christopher Mansell, Graziano de’ Petris, Deborah Bonazza, Fabrizio Zanconati, Alexey Melnikov, Fabio Cavalli. Hybrid Quantum Image Classification and Federated Learning for Hepatic Steatosis Diagnosis. Diagnostics 2024; 14(5) doi: 10.3390/diagnostics14050558
|
| 494 |
Md Akheruzzaman, Vijay Hegde, Andrew C. Shin, Nikhil V. Dhurandhar. Reducing endogenous insulin is linked with protection against hepatic steatosis in mice. Nutrition & Diabetes 2020; 10(1) doi: 10.1038/s41387-020-0114-9
|
| 495 |
Sok Kuan Wong, Kok-Yong Chin, Fairus Ahmad, Soelaiman Ima-Nirwana. Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver disease. Journal of Functional Foods 2020; 74 doi: 10.1016/j.jff.2020.104209
|
| 496 |
Roi Isaac, Gautam Bandyopadhyay, Theresa V. Rohm, Sion Kang, Jinyue Wang, Narayan Pokhrel, Sadatsugu Sakane, Rizaldy Zapata, Avraham M. Libster, Yaron Vinik, Asres Berhan, Tatiana Kisseleva, Zea Borok, Yehiel Zick, Francesca Telese, Nicholas J.G. Webster, Jerrold M. Olefsky. TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis. Cell Metabolism 2024; 36(5) doi: 10.1016/j.cmet.2024.04.003
|
| 497 |
Navya Malladi, Devidas Lahamge, Balaji Sanjay Somwanshi, Vikas Tiwari, Kajal Deshmukh, Jagdish Kumar Balani, Samhita Chakraborty, Md Jahangir Alam, Sanjay K. Banerjee. Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation. Cellular Signalling 2024; 121 doi: 10.1016/j.cellsig.2024.111299
|
| 498 |
Simona Todisco, Anna Santarsiero, Paolo Convertini, Giulio De Stefano, Michele Gilio, Vito Iacobazzi, Vittoria Infantino. PPAR Alpha as a Metabolic Modulator of the Liver: Role in the Pathogenesis of Nonalcoholic Steatohepatitis (NASH). Biology 2022; 11(5) doi: 10.3390/biology11050792
|
| 499 |
Anuththara Upamali Abeykoon, Madhavi Priyanka Paranagama, Kavindra Kumara Wijesundera, Onela Canith Pathirana, Thilini Anupama Mahakapuge, Jayantha Rajapakse. In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse model. BMC Complementary Medicine and Therapies 2025; 25(1) doi: 10.1186/s12906-025-04918-7
|
| 500 |
Yadi Li, Yan Yang, Yufang Li, Ping Zhang, Gaiying Ge, Jing Jin, Ting Du, Maiyan Ma, Li Na, Lu Ding, Huiping Sheng. Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis. Journal of International Medical Research 2021; 49(11) doi: 10.1177/03000605211055378
|
| 501 |
Daniela Sciancalepore, Maria Teresa Zingaro, Chiara Valentina Luglio, Carlo Sabbà, Nicola Napoli. Hepatocellular Carcinoma: Known and Emerging Risk Factors. Journal of Cancer Therapy 2018; 9(05) doi: 10.4236/jct.2018.95037
|
| 502 |
Homayoon BASHIRI, Arezoo BOZORGOMID, Vahid SHOJAEIMOTLAGH. Efficacy of Hijamat (wet cupping therapy) in Iranian patients with nonalcoholic fatty liver disease: a controlled clinical trial. TURKISH JOURNAL OF MEDICAL SCIENCES 2020; 44(2) doi: 10.3906/sag-1907-82
|
| 503 |
P. Vineeth Daniel, Surbhi Dogra, Priya Rawat, Abhinav Choubey, Aiysha Siddiq Khan, Sangam Rajak, Mohan Kamthan, Prosenjit Mondal. NF-κB p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet. Journal of Biological Chemistry 2021; 296 doi: 10.1016/j.jbc.2021.100714
|
| 504 |
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; doi: 10.1007/978-3-319-75856-5_21
|
| 505 |
Linghuan Gao, Xindi Wang, Lei Guo, Wenli Zhang, Gengyin Wang, Shuying Han, Yuxin Zhang. Sex differences in diabetes‑induced hepatic and renal damage. Experimental and Therapeutic Medicine 2024; 27(4) doi: 10.3892/etm.2024.12436
|
| 506 |
Waqas B. Khalid, Nadim Farhat, Linda Lavery, Josh Jarnagin, James P. Delany, Kang Kim. Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content. Ultrasound in Medicine & Biology 2021; 47(4) doi: 10.1016/j.ultrasmedbio.2020.12.014
|
| 507 |
Ting Qiu, Xiaodong Zhu, Jingju Wu, Wenyuan Hong, Weitao Hu, Taiyong Fang. Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92282-4
|
| 508 |
Alexander Myint. Improvement of liver function and glycemic control with Combination of DPP-4 inhibitors and GLP-1 agonists in type II diabetes mellitus patients with non-alcoholic steatohepatitis. Gastroenterology & Hepatology: Open Access 2020; 11(3) doi: 10.15406/ghoa.2020.11.00427
|
| 509 |
Mona A. El-Bana, Magdi N. Ashour, Wafaa I. Rasheed, Yasser M. Diab, Dalia Medhat.
Bombax ceiba Linn. leaf extract rich in phenolic compounds to mitigate non-alcoholic fatty liver-related complications in experimental model. Journal of Complementary and Integrative Medicine 2023; 20(2) doi: 10.1515/jcim-2021-0479
|
| 510 |
Krishnan Silja, Natarajan Selvaganabathy, Thiyagarajan Kalaiselvi, Chinnasamy Thirunavukkarasu. Inhibition of glutathione generation in hepatic steatotic rats augments oxidative stress. Toxicology Mechanisms and Methods 2023; 33(7) doi: 10.1080/15376516.2023.2202784
|
| 511 |
Venkat R. Pannala, Shanea K. Estes, Mohsin Rahim, Irina Trenary, Tracy P. O’Brien, Chiyo Shiota, Richard L. Printz, Jaques Reifman, Masakazu Shiota, Jamey D. Young, Anders Wallqvist. Toxicant-Induced Metabolic Alterations in Lipid and Amino Acid Pathways Are Predictive of Acute Liver Toxicity in Rats. International Journal of Molecular Sciences 2020; 21(21) doi: 10.3390/ijms21218250
|
| 512 |
Juan Li, Jiaxin Xu, Fangfang Zhu, Chun Wang. Effective treatment for fatty liver of liraglutide via inhibiting endoplasmic reticulum stress, oxidative stress and apoptosis pathways. Archives of Medical Science 2024; doi: 10.5114/aoms/186658
|
| 513 |
Nuria Perez-Diaz-del-Campo, Itziar Abete, Irene Cantero, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, M. Angeles Zulet. Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease. Nutrients 2020; 12(5) doi: 10.3390/nu12051260
|
| 514 |
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. The Journal of Steroid Biochemistry and Molecular Biology 2019; 194 doi: 10.1016/j.jsbmb.2019.105445
|
| 515 |
Gonçalo Martins Pereira, Sofia S. Pereira, Madalena Santos, José Brito, Diamantino Freitas, António Oliveira de Carvalho, Artur Águas, Maria João Oliveira, Pedro Oliveira. Effects of high-intensity infrasound on liver lipid content of rats. Heliyon 2020; 6(7) doi: 10.1016/j.heliyon.2020.e04383
|
| 516 |
Nahum Mendez-Sanchez, Vania Cesar Cruz-Ramon, Oscar Lenin Ramirez-Perez, Jessica P. Hwang, Beatriz Barranco-Fragoso, Jaqueline Cordova-Gallardo. New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2018; 19(7) doi: 10.3390/ijms19072034
|
| 517 |
M. V. Pecherskikh, L. I. Efremova. Intrahepatic cholestasis and its correction in patients with chronic acalculous cholecystitis. Experimental and Clinical Gastroenterology 2023; (5) doi: 10.31146/1682-8658-ecg-213-5-66-72
|
| 518 |
Meiling Liu, Sunmin Park. The Role of PNPLA3_rs738409 Gene Variant, Lifestyle Factors, and Bioactive Compounds in Nonalcoholic Fatty Liver Disease: A Population-Based and Molecular Approach towards Healthy Nutrition. Nutrients 2024; 16(8) doi: 10.3390/nu16081239
|
| 519 |
Lankai Cathy Xu, Maricela Rangel-Garcia, Rogelio Pinon-Gutierrez, Jeffrey R Fine, Valentina Medici, Alessio Molfino. Liver fibrosis prediction models in a population of Latina and White women. Journal of Investigative Medicine 2024; 72(7) doi: 10.1177/10815589241262004
|
| 520 |
Wen-Chung Huang, Ya-Ling Chen, Hui-Chia Liu, Shu-Ju Wu, Chian-Jiun Liou. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cells. Saudi Pharmaceutical Journal 2018; 26(8) doi: 10.1016/j.jsps.2018.07.006
|
| 521 |
Zaida Zainal, Huzwah Khaza'ai, Ammu Kutty Radhakrishnan, Sui Kiat Chang. Therapeutic potential of palm oil vitamin E-derived tocotrienols in inflammation and chronic diseases: Evidence from preclinical and clinical studies. Food Research International 2022; 156 doi: 10.1016/j.foodres.2022.111175
|
| 522 |
Fatemeh Naeini, Zahra Namkhah, Alireza Ostadrahimi, Helda Tutunchi, Mohammad Javad Hosseinzadeh-Attar. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease. Advances in Nutrition 2021; 12(2) doi: 10.1093/advances/nmaa106
|
| 523 |
Roberta Forlano, Mathuri Sivakumar, Benjamin H. Mullish, Pinelopi Manousou. Gut Microbiota—A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158307
|
| 524 |
Helda Tutunchi, Majid Mobasseri, Naser Aghamohammadzadeh, Jalil Hooshyar, Fatemeh Naeini, Farzad Najafipour. Serum neuregulin 4 (NRG‐4) level and non‐alcoholic fatty liver disease (NAFLD): A case‐control study. International Journal of Clinical Practice 2021; 75(10) doi: 10.1111/ijcp.14555
|
| 525 |
Farid Hajibonabi, Erica L. Riedesel, Susan D. Taylor, Leann E. Linam, Adina L. Alazraki, Chao Zhang, Geetika Khanna. Ultrasound-estimated hepatorenal index: diagnostic performance and interobserver agreement for pediatric liver fat quantification. Pediatric Radiology 2024; 54(10) doi: 10.1007/s00247-024-06021-4
|
| 526 |
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. Sweeteners. Reference Series in Phytochemistry 2018; doi: 10.1007/978-3-319-54528-8_57-1
|
| 527 |
Sabrina Pagano, Stephan J. L. Bakker, Catherine Juillard, Robin P. F. Dullaart, Nicolas Vuilleumier. Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease. Biomolecules 2023; 13(7) doi: 10.3390/biom13071128
|
| 528 |
Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al-Salami, Karmen Stankov, Momir Mikov. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01382
|
| 529 |
Berangere Gapp, Marie Jourdain, Pauline Bringer, Benjamin Kueng, Delphine Weber, Arnaud Osmont, Stefan Zurbruegg, Judith Knehr, Rocco Falchetto, Guglielmo Roma, William Dietrich, Reginald Valdez, Nicolau Beckmann, Florian Nigsch, Arun J. Sanyal, Iwona Ksiazek. Farnesoid X Receptor Agonism, Acetyl‐Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH Model. Hepatology Communications 2020; 4(1) doi: 10.1002/hep4.1443
|
| 530 |
Umberto Maria Battisti, Chunixa Gao, Fady Akladios, Woonghee Kim, Hong Yang, Cemil Bayram, Ismail Bolat, Metin Kiliclioglu, Nursena Yuksel, Ozlem Ozdemir Tozlu, Cheng Zhang, Jihad Sebhaoui, Shazia Iqbal, Saeed Shoaie, Ahmet Hacimuftuoglu, Serkan Yildirim, Hasan Turkez, Mathias Uhlen, Jan Boren, Adil Mardinoglu, Morten Grøtli. Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase. Nutrients 2023; 15(3) doi: 10.3390/nu15030577
|
| 531 |
Karen J. Campoverde Reyes, Javier Guevara, Hamidreza Karimi-Sari, Daniela Goyes, Kamolyut Lapumnuaypol, Pir A. Shah, Satinder P. Kaur, Margery A. Connelly, Z. Gordon Jiang, Daryl T.-Y. Lau. Differential NMR Lipoprotein Profiles and Prediction of Insulin Resistance and Metabolic Syndrome by LP-IR Among Adult Chronic Hepatitis B Patients. Journal of Clinical Medicine 2025; 14(20) doi: 10.3390/jcm14207405
|
| 532 |
Sepiso K. Masenga, Lweendo Muchaili, Benson M. Hamooya. Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease. AIDS 2023; 37(8) doi: 10.1097/QAD.0000000000003562
|
| 533 |
Ji-Youn Kim, Gyu-Na Lee, Hyun Chul Song, Yong-Moon Park, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko. Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination Survey. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60797-7
|
| 534 |
Ceri‐Anne E. Suurmond, Soufian Lasli, Floor W. van den Dolder, Aly Ung, Han‐Jun Kim, Praveen Bandaru, KangJu Lee, Hyun‐Jong Cho, Samad Ahadian, Nureddin Ashammakhi, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer Cells. Advanced Healthcare Materials 2019; 8(24) doi: 10.1002/adhm.201901379
|
| 535 |
S.M. Touhidul Islam, Jeseong Won, Mushfiquddin Khan, Kenneth D. Chavin, Inderjit Singh. Peroxisomal footprint in the pathogenesis of nonalcoholic steatohepatitis. Annals of Hepatology 2020; 19(5) doi: 10.1016/j.aohep.2019.11.007
|
| 536 |
Jonathan B. Steinman, Marcela A. Salomao, Utpal B. Pajvani. Zonation in NASH – A key paradigm for understanding pathophysiology and clinical outcomes. Liver International 2021; 41(11) doi: 10.1111/liv.15025
|
| 537 |
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 2019; 101 doi: 10.1016/j.metabol.2019.154001
|
| 538 |
M. Bellan, M. Menegatti, C. Ferrari, G.P. Carnevale Schianca, M. Pirisi. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice. Nutrition, Metabolism and Cardiovascular Diseases 2018; 28(6) doi: 10.1016/j.numecd.2018.01.006
|
| 539 |
Razk Abdalgwad, Mohammed Faraz Rafey, Conor Murphy, Iulia Ioana, Paula Mary O’Shea, Eoin Slattery, Colin Davenport, Derek Timothy O’Keeffe, Francis Martin Finucane. Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme. Nutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-020-00512-5
|
| 540 |
Tanmoy Banerjee, Arnab Sarkar, Sk Zeeshan Ali, Rudranil Bhowmik, Sanmoy Karmakar, Amit Kumar Halder, Nilanjan Ghosh. Bioprotective Role of Phytocompounds Against the Pathogenesis of Non-alcoholic Fatty Liver Disease to Non-alcoholic Steatohepatitis: Unravelling Underlying Molecular Mechanisms. Planta Medica 2024; 90(09) doi: 10.1055/a-2277-4805
|
| 541 |
Huanfen Lu, Zhenglan Ban, Kai Xiao, Madi Sun, Yongbo Liu, Fangman Chen, Tongfei Shi, Li Chen, Dan Shao, Ming Zhang, Wei Li. Hepatic‐Accumulated Obeticholic Acid and Atorvastatin Self‐Assembled Nanocrystals Potentiate Ameliorative Effects in Treatment of Metabolic‐Associated Fatty Liver Disease. Advanced Science 2024; 11(10) doi: 10.1002/advs.202308866
|
| 542 |
Kamil Doğan, Ergül Belge Kurutaş, Velid Ünsal, Murat İspiroğlu, Mürvet Yüksel. Relationship between ultrasonographic liver steatosis degree and oxidative/nitrosative stress in patients diagnosed with metabolic dysfunction-associated steatotic liver disease. Anatolian Current Medical Journal 2024; 6(6) doi: 10.38053/acmj.1557448
|
| 543 |
Luis Fontana, Julio Plaza-Díaz, Paula Robles-Bolívar, Héctor Valente-Godínez, María José Sáez-Lara, Francisco Abadía-Molina, Carolina Gómez-Llorente, Ángel Gil, Ana I. Álvarez-Mercado. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Leprfa/fa Rats. Nutrients 2021; 13(1) doi: 10.3390/nu13010202
|
| 544 |
Pegah Jahani, Mohammad Reza Fattahi, Mojtaba Neydavoodi, Zeinab Gholami. Correlation of Liver Fibroscan Results with Liver Elastographyand Liver Enzymes in Patients with Fatty Liver. Journal of Kermanshah University of Medical Sciences 2024; 29(1) doi: 10.5812/jkums-142386
|
| 545 |
Panagiotis Theofilis, Aikaterini Vordoni, Nikolaos Nakas, Rigas G. Kalaitzidis. Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Life 2022; 12(5) doi: 10.3390/life12050718
|
| 546 |
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway. Journal of Proteome Research 2020; 19(7) doi: 10.1021/acs.jproteome.9b00405
|
| 547 |
Narisara Paradee, Thararat Yimcharoen, Niramon Utama‐ang, Kornvipa Settakorn, Hataichanok Chuljerm, Somdet Srichairatanakool, Pimpisid Koonyosying. Phytochemical Analysis and Anti‐Lipid Accumulation Effects of Pulsed Electric Field (PEF)‐Processed Black Rice and Green Tea Extracts in Oleic Acid‐Induced Hepatocytes. Food Science & Nutrition 2025; 13(6) doi: 10.1002/fsn3.70329
|
| 548 |
|
| 549 |
Victor Enrique Sarmiento-Ortega, Diana Moroni-González, Alfonso Díaz, Brambila Eduardo, Treviño Samuel. Oral Subacute Exposure to Cadmium LOAEL Dose Induces Insulin Resistance and Impairment of the Hormonal and Metabolic Liver-Adipose Axis in Wistar Rats. Biological Trace Element Research 2022; 200(10) doi: 10.1007/s12011-021-03027-z
|
| 550 |
Igor V. Maev, Alexey A. Samsonov, Leonid B. Lazebnik, Elena V. Golovanova, Chavdar S. Pavlov, Elena I. Vovk, Vlad Ratziu, Kirill M. Starostin. A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease. Advances in Therapy 2020; 37(11) doi: 10.1007/s12325-020-01493-w
|
| 551 |
Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, Giorgia Polti, Giovanni Iannetti, Vito D’Andrea, Salvatore Sorrenti, Vito Cantisani, Carla Lubrano, Eleonora Lori, Elena Gangitano. Nonalcoholic fatty liver disease and diabetes. World Journal of Diabetes 2022; 13(9): 668-682 doi: 10.4239/wjd.v13.i9.668
|
| 552 |
Vikrant Sood, Snehavardhan Pandey, Mohit Kehar, Alexandre Louvet, Mariana M. Ramírez-Mejía, Nahum Méndez-Sánchez. Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024; doi: 10.1007/978-981-97-9519-2_12
|
| 553 |
Heba Abdel Rahman Eltony, Gamal Kasem, Radwa Mahmoud Elsharaby, Rehab Badawi, Eman M. Helal. Non-invasive detection of fibrosis in non-alcoholic fatty liver disease by serum microfibrillar-associated protein 4 and its correlation with FIB-4 and transient elastography. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00439-7
|
| 554 |
Dixa Sharma, Palash Mandal. NAFLD: genetics and its clinical implications. Clinics and Research in Hepatology and Gastroenterology 2022; 46(9) doi: 10.1016/j.clinre.2022.102003
|
| 555 |
Muhammad Farooq, Huma Hameed, Marie-Thérèse Dimanche-Boitrel, Claire Piquet-Pellorce, Michel Samson, Jacques Le Seyec. Switching to Regular Diet Partially Resolves Liver Fibrosis Induced by High-Fat, High-Cholesterol Diet in Mice. Nutrients 2022; 14(2) doi: 10.3390/nu14020386
|
| 556 |
Gabriel Heymann, Saumik Rahman, Daniel Kats, Bubu A Banini, Srinivas Gaddam, Elise Aslanian, Sarpong Boateng, Gary Israel, Thiruvengadam Muniraj. Pancreatic steatosis is not associated with advanced steatohepatitis or fibrosis in metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology 2025; 31(47): 114651 doi: 10.3748/wjg.v31.i47.114651
|
| 557 |
Yue Xiong, Yan Chen, Xinping Huang, Zhen Yang, Jiaye Zhang, Xiaorui Yu, Ji Fang, Jiawang Tao, Kai You, Ziqi Cheng, Shenglin Tan, Yingying Xu, Fang Yuan, Ying Liu, Yuanqi Zhuang, Fan Yang, Yinxiong Li. Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity. Life Sciences 2021; 268 doi: 10.1016/j.lfs.2020.119000
|
| 558 |
Nehal Mohamed Bahgat Gamil, Sahar Mohamed El Agaty, Gehan Khalaf Megahed, Rania Salah Mansour, Marwa Saad Abdel-Latif. Reversion to regular diet with alternate day fasting can cure grade-I non-alcoholic fatty liver disease (NAFLD) in high-fructose-intake-associated metabolic syndrome. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00128-1
|
| 559 |
Hyeon Ju Kim, Yoseob Lee, Sungsoon Fang, Won Kim, Hyo Jung Kim, Jae-woo Kim. GPx7 ameliorates non-alcoholic steatohepatitis by regulating oxidative stress. BMB Reports 2020; 53(6) doi: 10.5483/BMBRep.2020.53.6.280
|
| 560 |
Giovanni Inzalaco, Sara Gargiulo, Denise Bonente, Lisa Gherardini, Lorenzo Franci, Nicla Lorito, Serena Del Turco, Danilo Tatoni, Tiziana Tamborrino, Federico Galvagni, Eugenio Bertelli, Romina D’Aurizio, Maria Grazia Andreassi, Giuseppina Basta, Amalia Gastaldelli, Andrea Morandi, Virginia Barone, Mario Chiariello. MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic disease. Hepatology Communications 2026; 10(2) doi: 10.1097/HC9.0000000000000870
|
| 561 |
Sumit Roy, Vancha Harish, Sharfuddin Mohd, Sachin Kumar Singh. Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment. Advanced Therapeutics 2024; 7(9) doi: 10.1002/adtp.202400126
|
| 562 |
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iranian Biomedical Journal 2022; 26(4) doi: 10.52547/ibj.3647
|
| 563 |
Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen, Robin P. F. Dullaart. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease. European Journal of Clinical Investigation 2018; 48(9) doi: 10.1111/eci.12988
|
| 564 |
Imane Mokhtari, Chakib Mokhtari, Mohammadine Moumou, Mohamed Harnafi, Dragan Milenkovic, Souliman Amrani, Abdelmalek Hakmaoui, Hicham Harnafi. Polyphenol-rich extract from loquat fruit peel prevents hyperlipidemia and hepato-nephrotoxicity in mice: in vivo study and in silico prediction of possible mechanisms involving identified polyphenols and/or their circulating metabolites. Food & Function 2023; 14(16) doi: 10.1039/D3FO01992F
|
| 565 |
Qian Yang, Mohammed Abed Jawad, Abdullah Ali Alzahrani, Zahraa F Hassan, Ahmed Elawady, Ahmed Hjazi, Mehran Naghibi. Synergistic effects of Metformin and Forskolin on oxidative stress induced by diabetes and hepatocellular cancer: An animal study. Toxicon 2024; 243 doi: 10.1016/j.toxicon.2024.107720
|
| 566 |
Musaab Ahmed. Ramadan Fasting and Complications of Metabolic Dysfunction-Associated Steatotic Liver Disease: Impacts on Liver Cirrhosis and Heart Failure. Journal of Clinical Medicine 2025; 14(6) doi: 10.3390/jcm14061841
|
| 567 |
Nitish Singh Jangwan, Mausin Khan, Richa Das, Najla Altwaijry, Ahlam Mansour Sultan, Ruqaiyah Khan, Shakir Saleem, Mamta F. Singh. From petals to healing: consolidated network pharmacology and molecular docking investigations of the mechanisms underpinning Rhododendron arboreum flower’s anti-NAFLD effects. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1366279
|
| 568 |
Jona T. Stahmeyer, Melissa Hemmerling, Birte Burger, Sveja Eberhard, Christian Krauth, Jan Zeidler, Annika Herr, Henning Weseloh, Siegbert Rossol. Die Häufigkeit von diagnostizierten Fettlebererkrankungen (NAFLD) in der deutschen Bevölkerung – Eine Analyse auf der Basis von GKV-Routinedaten. Zeitschrift für Gastroenterologie 2021; 59(08) doi: 10.1055/a-1402-1263
|
| 569 |
Ayesha Monga Kravetz, Todd Testerman, Brittany Galuppo, Joerg Graf, Bridget Pierpont, Stephan Siebel, Richard Feinn, Nicola Santoro. Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth. The Journal of Clinical Endocrinology & Metabolism 2020; 105(10) doi: 10.1210/clinem/dgaa382
|
| 570 |
Wenqian Xu, Hongkang Zhu, Bin Hu, Yuliang Cheng, Yahui Guo, Weirong Yao, He Qian. Echinacea in hepatopathy: A review of its phytochemistry, pharmacology, and safety. Phytomedicine 2021; 87 doi: 10.1016/j.phymed.2021.153572
|
| 571 |
Junli Zhang, Haiming Zhang, Xiaoling Deng, Ning Zhang, Beibei Liu, Shengliang Xin, Guixin Li, Keshu Xu. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Life Sciences 2018; 192 doi: 10.1016/j.lfs.2017.11.027
|
| 572 |
Ju Zou, Jie Li, Xiaoxu Wang, Daolin Tang, Ruochan Chen. Neuroimmune modulation in liver pathophysiology. Journal of Neuroinflammation 2024; 21(1) doi: 10.1186/s12974-024-03181-w
|
| 573 |
Shaaron Ochoa-Rios, Ian P. O'Connor, Lindsey N. Kent, Julian M. Clouse, Yannis Hadjiyannis, Christopher Koivisto, Thierry Pecot, Peggi M. Angel, Richard R. Drake, Gustavo Leone, Anand S. Mehta, Don C. Rockey. Imaging Mass Spectrometry Reveals Alterations in N-Linked Glycosylation That Are Associated With Histopathological Changes in Nonalcoholic Steatohepatitis in Mouse and Human. Molecular & Cellular Proteomics 2022; 21(5) doi: 10.1016/j.mcpro.2022.100225
|
| 574 |
Shu-Fu Shih, Holden H. Wu. Free-breathing MRI techniques for fat and R2* quantification in the liver. Magnetic Resonance Materials in Physics, Biology and Medicine 2024; 37(4) doi: 10.1007/s10334-024-01187-2
|
| 575 |
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan. Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review). Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7781
|
| 576 |
Afshan Syed Abbas, Tasleem Akhtar, Najma Shaheen, Sumaira Aslam, Nadeem Sheikh. Mechanistic study of regulation of iron homeostasis by N. sativa seeds and P. ovata husks on high fat/high sucrose diet induced non-alcoholic fatty liver disease. Molecular Biology Reports 2022; 49(8) doi: 10.1007/s11033-022-07538-3
|
| 577 |
Fadl H Veerankutty, Govind Jayan, Manish Kumar Yadav, Krishnan Sarojam Manoj, Abhishek Yadav, Sindhu Radha Sadasivan Nair, T U Shabeerali, Varghese Yeldho, Madhu Sasidharan, Shiraz Ahmad Rather. Artificial Intelligence in hepatology, liver surgery and transplantation: Emerging applications and frontiers of research. World Journal of Hepatology 2021; 13(12): 1977-1990 doi: 10.4254/wjh.v13.i12.1977
|
| 578 |
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Comprehensive Gut Microbiota. 2022; doi: 10.1016/B978-0-12-819265-8.00079-6
|
| 579 |
Gargi Dixit, Arati Prabhu. The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics. Experimental and Molecular Pathology 2022; 124 doi: 10.1016/j.yexmp.2021.104723
|
| 580 |
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan. Comprehensive Physiology. 2022; doi: 10.1002/cphy.c200021
|
| 581 |
Louis Papageorgiou, Eleni Papakonstantinou, Io Diakou, Katerina Pierouli, Konstantina Dragoumani, Flora Bacopoulou, George P. Chrousos, Elias Eliopoulos, Dimitrios Vlachakis. GeNeDis 2022. Advances in Experimental Medicine and Biology 2023; 1423 doi: 10.1007/978-3-031-31978-5_6
|
| 582 |
Nicolás Salva-Pastor, Mayra Domínguez-Pérez, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. Clinical Bioenergetics. 2021; doi: 10.1016/B978-0-12-819621-2.00006-1
|
| 583 |
Ankur Maity, Sayed Mohammed Firdous, Deep Pathak, Bijoy Paria. Unrevealing the Role of Flavonoids in Mitigation of Non-Alcoholic Fatty Liver Disease. Medicinal Chemistry Research 2026; 35(6) doi: 10.1007/s00044-026-03564-z
|